CN115707778B - 重组柯萨奇病毒a10病毒样颗粒及其用途 - Google Patents
重组柯萨奇病毒a10病毒样颗粒及其用途 Download PDFInfo
- Publication number
- CN115707778B CN115707778B CN202110962246.7A CN202110962246A CN115707778B CN 115707778 B CN115707778 B CN 115707778B CN 202110962246 A CN202110962246 A CN 202110962246A CN 115707778 B CN115707778 B CN 115707778B
- Authority
- CN
- China
- Prior art keywords
- thr
- ala
- val
- coxsackievirus
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000146367 Coxsackievirus A10 Species 0.000 title claims abstract description 88
- 239000002245 particle Substances 0.000 title claims abstract description 39
- 108090000565 Capsid Proteins Proteins 0.000 claims abstract description 55
- 102100023321 Ceruloplasmin Human genes 0.000 claims abstract description 55
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 229960005486 vaccine Drugs 0.000 claims abstract description 16
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 15
- 208000020061 Hand, Foot and Mouth Disease Diseases 0.000 claims abstract description 7
- 208000025713 Hand-foot-and-mouth disease Diseases 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000002773 nucleotide Substances 0.000 claims description 49
- 125000003729 nucleotide group Chemical group 0.000 claims description 49
- 102000039446 nucleic acids Human genes 0.000 claims description 23
- 108020004707 nucleic acids Proteins 0.000 claims description 23
- 150000007523 nucleic acids Chemical class 0.000 claims description 23
- 108091033319 polynucleotide Proteins 0.000 claims description 22
- 102000040430 polynucleotide Human genes 0.000 claims description 22
- 239000002157 polynucleotide Substances 0.000 claims description 22
- 150000001413 amino acids Chemical group 0.000 claims description 21
- 239000013604 expression vector Substances 0.000 claims description 11
- 239000003937 drug carrier Substances 0.000 claims description 7
- 241000235648 Pichia Species 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 241000709687 Coxsackievirus Species 0.000 abstract description 19
- 241000699670 Mus sp. Species 0.000 abstract description 10
- 230000005847 immunogenicity Effects 0.000 abstract description 9
- 230000028993 immune response Effects 0.000 abstract description 7
- 208000030194 mouth disease Diseases 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 5
- 230000006806 disease prevention Effects 0.000 abstract description 3
- 101710132601 Capsid protein Proteins 0.000 description 52
- 101710197658 Capsid protein VP1 Proteins 0.000 description 52
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 52
- 101710108545 Viral protein 1 Proteins 0.000 description 52
- 230000014509 gene expression Effects 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 230000003053 immunization Effects 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 9
- 108010061238 threonyl-glycine Proteins 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 238000002649 immunization Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 238000003776 cleavage reaction Methods 0.000 description 7
- 230000007017 scission Effects 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 6
- 241000235058 Komagataella pastoris Species 0.000 description 6
- 101710172711 Structural protein Proteins 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 108010037850 glycylvaline Proteins 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 108010050848 glycylleucine Proteins 0.000 description 5
- 108010092114 histidylphenylalanine Proteins 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108010029020 prolylglycine Proteins 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 108010026333 seryl-proline Proteins 0.000 description 5
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 5
- ANAHQDPQQBDOBM-UHFFFAOYSA-N Arg-Val-Tyr Natural products CC(C)C(NC(=O)C(N)CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O ANAHQDPQQBDOBM-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- OGCQGUIWMSBHRZ-CIUDSAMLSA-N Leu-Asn-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OGCQGUIWMSBHRZ-CIUDSAMLSA-N 0.000 description 4
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 4
- JHNOXVASMSXSNB-WEDXCCLWSA-N Lys-Thr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JHNOXVASMSXSNB-WEDXCCLWSA-N 0.000 description 4
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 4
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 4
- KCRQEJSKXAIULJ-FJXKBIBVSA-N Thr-Gly-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCRQEJSKXAIULJ-FJXKBIBVSA-N 0.000 description 4
- UQCNIMDPYICBTR-KYNKHSRBSA-N Thr-Thr-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UQCNIMDPYICBTR-KYNKHSRBSA-N 0.000 description 4
- UDLYXGYWTVOIKU-QXEWZRGKSA-N Val-Asn-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UDLYXGYWTVOIKU-QXEWZRGKSA-N 0.000 description 4
- 108010044940 alanylglutamine Proteins 0.000 description 4
- 108010060035 arginylproline Proteins 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 108010060199 cysteinylproline Proteins 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 108010081551 glycylphenylalanine Proteins 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 108010038320 lysylphenylalanine Proteins 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 3
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 3
- BKFXFUPYETWGGA-XVSYOHENSA-N Asn-Phe-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BKFXFUPYETWGGA-XVSYOHENSA-N 0.000 description 3
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000880493 Leptailurus serval Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- 108010079364 N-glycylalanine Proteins 0.000 description 3
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 3
- YYKZDTVQHTUKDW-RYUDHWBXSA-N Phe-Gly-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N YYKZDTVQHTUKDW-RYUDHWBXSA-N 0.000 description 3
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 3
- UEHYFUCOGHWASA-HJGDQZAQSA-N Pro-Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 UEHYFUCOGHWASA-HJGDQZAQSA-N 0.000 description 3
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 3
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 108010005233 alanylglutamic acid Proteins 0.000 description 3
- 108010093581 aspartyl-proline Proteins 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000002296 dynamic light scattering Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 108010078144 glutaminyl-glycine Proteins 0.000 description 3
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000003118 sandwich ELISA Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- CWFMWBHMIMNZLN-NAKRPEOUSA-N (2s)-1-[(2s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CWFMWBHMIMNZLN-NAKRPEOUSA-N 0.000 description 2
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 2
- JYEBJTDTPNKQJG-FXQIFTODSA-N Ala-Asn-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N JYEBJTDTPNKQJG-FXQIFTODSA-N 0.000 description 2
- YIGLXQRFQVWFEY-NRPADANISA-N Ala-Gln-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O YIGLXQRFQVWFEY-NRPADANISA-N 0.000 description 2
- IFKQPMZRDQZSHI-GHCJXIJMSA-N Ala-Ile-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O IFKQPMZRDQZSHI-GHCJXIJMSA-N 0.000 description 2
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 2
- OMDNCNKNEGFOMM-BQBZGAKWSA-N Ala-Met-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O OMDNCNKNEGFOMM-BQBZGAKWSA-N 0.000 description 2
- XSTZMVAYYCJTNR-DCAQKATOSA-N Ala-Met-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XSTZMVAYYCJTNR-DCAQKATOSA-N 0.000 description 2
- WQLDNOCHHRISMS-NAKRPEOUSA-N Ala-Pro-Ile Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WQLDNOCHHRISMS-NAKRPEOUSA-N 0.000 description 2
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- JJHBEVZAZXZREW-LFSVMHDDSA-N Ala-Thr-Phe Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O JJHBEVZAZXZREW-LFSVMHDDSA-N 0.000 description 2
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 2
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 2
- XPBVBZPVNFIHOA-UVBJJODRSA-N Ala-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 XPBVBZPVNFIHOA-UVBJJODRSA-N 0.000 description 2
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 2
- QRIYOHQJRDHFKF-UWJYBYFXSA-N Ala-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 QRIYOHQJRDHFKF-UWJYBYFXSA-N 0.000 description 2
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 2
- 102100036826 Aldehyde oxidase Human genes 0.000 description 2
- OLDOLPWZEMHNIA-PJODQICGSA-N Arg-Ala-Trp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O OLDOLPWZEMHNIA-PJODQICGSA-N 0.000 description 2
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 2
- XVLLUZMFSAYKJV-GUBZILKMSA-N Arg-Asp-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XVLLUZMFSAYKJV-GUBZILKMSA-N 0.000 description 2
- RWDVGVPHEWOZMO-GUBZILKMSA-N Arg-Cys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O RWDVGVPHEWOZMO-GUBZILKMSA-N 0.000 description 2
- NXDXECQFKHXHAM-HJGDQZAQSA-N Arg-Glu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NXDXECQFKHXHAM-HJGDQZAQSA-N 0.000 description 2
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 2
- GIMTZGADWZTZGV-DCAQKATOSA-N Arg-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GIMTZGADWZTZGV-DCAQKATOSA-N 0.000 description 2
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 2
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 2
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 2
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 2
- WHLDJYNHXOMGMU-JYJNAYRXSA-N Arg-Val-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WHLDJYNHXOMGMU-JYJNAYRXSA-N 0.000 description 2
- CGXQUULXFWRJOI-SRVKXCTJSA-N Arg-Val-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O CGXQUULXFWRJOI-SRVKXCTJSA-N 0.000 description 2
- PDQBXRSOSCTGKY-ACZMJKKPSA-N Asn-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N PDQBXRSOSCTGKY-ACZMJKKPSA-N 0.000 description 2
- LEFKSBYHUGUWLP-ACZMJKKPSA-N Asn-Ala-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LEFKSBYHUGUWLP-ACZMJKKPSA-N 0.000 description 2
- IARGXWMWRFOQPG-GCJQMDKQSA-N Asn-Ala-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IARGXWMWRFOQPG-GCJQMDKQSA-N 0.000 description 2
- QEYJFBMTSMLPKZ-ZKWXMUAHSA-N Asn-Ala-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O QEYJFBMTSMLPKZ-ZKWXMUAHSA-N 0.000 description 2
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 2
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 2
- PTSDPWIHOYMRGR-UGYAYLCHSA-N Asn-Ile-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O PTSDPWIHOYMRGR-UGYAYLCHSA-N 0.000 description 2
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 2
- NNDSLVWAQAUPPP-GUBZILKMSA-N Asn-Met-Met Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N NNDSLVWAQAUPPP-GUBZILKMSA-N 0.000 description 2
- UXHYOWXTJLBEPG-GSSVUCPTSA-N Asn-Thr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UXHYOWXTJLBEPG-GSSVUCPTSA-N 0.000 description 2
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 2
- NECWUSYTYSIFNC-DLOVCJGASA-N Asp-Ala-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 NECWUSYTYSIFNC-DLOVCJGASA-N 0.000 description 2
- USNJAPJZSGTTPX-XVSYOHENSA-N Asp-Phe-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O USNJAPJZSGTTPX-XVSYOHENSA-N 0.000 description 2
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 2
- BKOIIURTQAJHAT-GUBZILKMSA-N Asp-Pro-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 BKOIIURTQAJHAT-GUBZILKMSA-N 0.000 description 2
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 2
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 2
- IWLZBRTUIVXZJD-OLHMAJIHSA-N Asp-Thr-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O IWLZBRTUIVXZJD-OLHMAJIHSA-N 0.000 description 2
- ALMIMUZAWTUNIO-BZSNNMDCSA-N Asp-Tyr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ALMIMUZAWTUNIO-BZSNNMDCSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- YFXFOZPXVFPBDH-VZFHVOOUSA-N Cys-Ala-Thr Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(O)=O YFXFOZPXVFPBDH-VZFHVOOUSA-N 0.000 description 2
- SDXQKJAWASHMIZ-CIUDSAMLSA-N Cys-Glu-Met Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O SDXQKJAWASHMIZ-CIUDSAMLSA-N 0.000 description 2
- VXLXATVURDNDCG-CIUDSAMLSA-N Cys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N VXLXATVURDNDCG-CIUDSAMLSA-N 0.000 description 2
- CAXGCBSRJLADPD-FXQIFTODSA-N Cys-Pro-Asn Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CAXGCBSRJLADPD-FXQIFTODSA-N 0.000 description 2
- 241001529459 Enterovirus A71 Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- YJIUYQKQBBQYHZ-ACZMJKKPSA-N Gln-Ala-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YJIUYQKQBBQYHZ-ACZMJKKPSA-N 0.000 description 2
- KVYVOGYEMPEXBT-GUBZILKMSA-N Gln-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O KVYVOGYEMPEXBT-GUBZILKMSA-N 0.000 description 2
- ODBLJLZVLAWVMS-GUBZILKMSA-N Gln-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N ODBLJLZVLAWVMS-GUBZILKMSA-N 0.000 description 2
- OIIIRRTWYLCQNW-ACZMJKKPSA-N Gln-Cys-Asn Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O OIIIRRTWYLCQNW-ACZMJKKPSA-N 0.000 description 2
- LWDGZZGWDMHBOF-FXQIFTODSA-N Gln-Glu-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LWDGZZGWDMHBOF-FXQIFTODSA-N 0.000 description 2
- IULKWYSYZSURJK-AVGNSLFASA-N Gln-Leu-Lys Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O IULKWYSYZSURJK-AVGNSLFASA-N 0.000 description 2
- YPFFHGRJCUBXPX-NHCYSSNCSA-N Gln-Pro-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(O)=O YPFFHGRJCUBXPX-NHCYSSNCSA-N 0.000 description 2
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 2
- PAOHIZNRJNIXQY-XQXXSGGOSA-N Gln-Thr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PAOHIZNRJNIXQY-XQXXSGGOSA-N 0.000 description 2
- CMFBOXUBWMZZMD-BPUTZDHNSA-N Gln-Trp-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N CMFBOXUBWMZZMD-BPUTZDHNSA-N 0.000 description 2
- WBBVTGIFQIZBHP-JBACZVJFSA-N Gln-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)N)N WBBVTGIFQIZBHP-JBACZVJFSA-N 0.000 description 2
- FHPXTPQBODWBIY-CIUDSAMLSA-N Glu-Ala-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHPXTPQBODWBIY-CIUDSAMLSA-N 0.000 description 2
- UTKICHUQEQBDGC-ACZMJKKPSA-N Glu-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N UTKICHUQEQBDGC-ACZMJKKPSA-N 0.000 description 2
- IRDASPPCLZIERZ-XHNCKOQMSA-N Glu-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N IRDASPPCLZIERZ-XHNCKOQMSA-N 0.000 description 2
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 2
- XEKAJTCACGEBOK-KKUMJFAQSA-N Glu-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XEKAJTCACGEBOK-KKUMJFAQSA-N 0.000 description 2
- YRMZCZIRHYCNHX-RYUDHWBXSA-N Glu-Phe-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O YRMZCZIRHYCNHX-RYUDHWBXSA-N 0.000 description 2
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 2
- OLTHVCNYJAALPL-BHYGNILZSA-N Glu-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)O)N)C(=O)O OLTHVCNYJAALPL-BHYGNILZSA-N 0.000 description 2
- QOOFKCCZZWTCEP-AVGNSLFASA-N Glu-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O QOOFKCCZZWTCEP-AVGNSLFASA-N 0.000 description 2
- UZWUBBRJWFTHTD-LAEOZQHASA-N Glu-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O UZWUBBRJWFTHTD-LAEOZQHASA-N 0.000 description 2
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 2
- QXPRJQPCFXMCIY-NKWVEPMBSA-N Gly-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN QXPRJQPCFXMCIY-NKWVEPMBSA-N 0.000 description 2
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 2
- LURCIJSJAKFCRO-QWRGUYRKSA-N Gly-Asn-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LURCIJSJAKFCRO-QWRGUYRKSA-N 0.000 description 2
- VOCMRCVMAPSSAL-IUCAKERBSA-N Gly-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CN VOCMRCVMAPSSAL-IUCAKERBSA-N 0.000 description 2
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 2
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 2
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 2
- YIFUFYZELCMPJP-YUMQZZPRSA-N Gly-Leu-Cys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O YIFUFYZELCMPJP-YUMQZZPRSA-N 0.000 description 2
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 2
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 2
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 2
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 2
- RHRLHXQWHCNJKR-PMVVWTBXSA-N Gly-Thr-His Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 RHRLHXQWHCNJKR-PMVVWTBXSA-N 0.000 description 2
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 2
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 2
- LYZYGGWCBLBDMC-QWHCGFSZSA-N Gly-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)CN)C(=O)O LYZYGGWCBLBDMC-QWHCGFSZSA-N 0.000 description 2
- DNAZKGFYFRGZIH-QWRGUYRKSA-N Gly-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 DNAZKGFYFRGZIH-QWRGUYRKSA-N 0.000 description 2
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 2
- LMMPTUVWHCFTOT-GARJFASQSA-N His-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O LMMPTUVWHCFTOT-GARJFASQSA-N 0.000 description 2
- IMPKSPYRPUXYAP-SZMVWBNQSA-N His-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CN=CN3)N IMPKSPYRPUXYAP-SZMVWBNQSA-N 0.000 description 2
- PQKCQZHAGILVIM-NKIYYHGXSA-N His-Glu-Thr Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(O)=O PQKCQZHAGILVIM-NKIYYHGXSA-N 0.000 description 2
- DYKZGTLPSNOFHU-DEQVHRJGSA-N His-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N DYKZGTLPSNOFHU-DEQVHRJGSA-N 0.000 description 2
- QCBYAHHNOHBXIH-UWVGGRQHSA-N His-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CN=CN1 QCBYAHHNOHBXIH-UWVGGRQHSA-N 0.000 description 2
- CWSZWFILCNSNEX-CIUDSAMLSA-N His-Ser-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CWSZWFILCNSNEX-CIUDSAMLSA-N 0.000 description 2
- PZAJPILZRFPYJJ-SRVKXCTJSA-N His-Ser-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O PZAJPILZRFPYJJ-SRVKXCTJSA-N 0.000 description 2
- WYKXJGWSJUULSL-AVGNSLFASA-N His-Val-Arg Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O WYKXJGWSJUULSL-AVGNSLFASA-N 0.000 description 2
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 2
- FVEWRQXNISSYFO-ZPFDUUQYSA-N Ile-Arg-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FVEWRQXNISSYFO-ZPFDUUQYSA-N 0.000 description 2
- NULSANWBUWLTKN-NAKRPEOUSA-N Ile-Arg-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N NULSANWBUWLTKN-NAKRPEOUSA-N 0.000 description 2
- IIXDMJNYALIKGP-DJFWLOJKSA-N Ile-Asn-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N IIXDMJNYALIKGP-DJFWLOJKSA-N 0.000 description 2
- XENGULNPUDGALZ-ZPFDUUQYSA-N Ile-Asn-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N XENGULNPUDGALZ-ZPFDUUQYSA-N 0.000 description 2
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 2
- SJIGTGZVQGLMGG-NAKRPEOUSA-N Ile-Cys-Arg Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)O SJIGTGZVQGLMGG-NAKRPEOUSA-N 0.000 description 2
- PNDMHTTXXPUQJH-RWRJDSDZSA-N Ile-Glu-Thr Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)O PNDMHTTXXPUQJH-RWRJDSDZSA-N 0.000 description 2
- FJWALBCCVIHZBS-QXEWZRGKSA-N Ile-Met-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)N FJWALBCCVIHZBS-QXEWZRGKSA-N 0.000 description 2
- NSPNUMNLZNOPAQ-SJWGOKEGSA-N Ile-Tyr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N NSPNUMNLZNOPAQ-SJWGOKEGSA-N 0.000 description 2
- DLEBSGAVWRPTIX-PEDHHIEDSA-N Ile-Val-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)[C@@H](C)CC DLEBSGAVWRPTIX-PEDHHIEDSA-N 0.000 description 2
- UYODHPPSCXBNCS-XUXIUFHCSA-N Ile-Val-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(C)C UYODHPPSCXBNCS-XUXIUFHCSA-N 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- IBMVEYRWAWIOTN-RWMBFGLXSA-N Leu-Arg-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(O)=O IBMVEYRWAWIOTN-RWMBFGLXSA-N 0.000 description 2
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 2
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 2
- SGIIOQQGLUUMDQ-IHRRRGAJSA-N Leu-His-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N SGIIOQQGLUUMDQ-IHRRRGAJSA-N 0.000 description 2
- OMHLATXVNQSALM-FQUUOJAGSA-N Leu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(C)C)N OMHLATXVNQSALM-FQUUOJAGSA-N 0.000 description 2
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 2
- REPBGZHJKYWFMJ-KKUMJFAQSA-N Leu-Lys-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N REPBGZHJKYWFMJ-KKUMJFAQSA-N 0.000 description 2
- FKQPWMZLIIATBA-AJNGGQMLSA-N Leu-Lys-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FKQPWMZLIIATBA-AJNGGQMLSA-N 0.000 description 2
- ONPJGOIVICHWBW-BZSNNMDCSA-N Leu-Lys-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ONPJGOIVICHWBW-BZSNNMDCSA-N 0.000 description 2
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 2
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 2
- ICYRCNICGBJLGM-HJGDQZAQSA-N Leu-Thr-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 2
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 2
- UCRJTSIIAYHOHE-ULQDDVLXSA-N Leu-Tyr-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UCRJTSIIAYHOHE-ULQDDVLXSA-N 0.000 description 2
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 2
- DFXQCCBKGUNYGG-GUBZILKMSA-N Lys-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN DFXQCCBKGUNYGG-GUBZILKMSA-N 0.000 description 2
- VSTNAUBHKQPVJX-IHRRRGAJSA-N Lys-Met-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O VSTNAUBHKQPVJX-IHRRRGAJSA-N 0.000 description 2
- ZZHPLPSLBVBWOA-WDSOQIARSA-N Lys-Met-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N ZZHPLPSLBVBWOA-WDSOQIARSA-N 0.000 description 2
- UDXSLGLHFUBRRM-OEAJRASXSA-N Lys-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N)O UDXSLGLHFUBRRM-OEAJRASXSA-N 0.000 description 2
- OBZHNHBAAVEWKI-DCAQKATOSA-N Lys-Pro-Asn Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O OBZHNHBAAVEWKI-DCAQKATOSA-N 0.000 description 2
- OBVHKUFUDCPZDW-JYJNAYRXSA-N Met-Arg-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OBVHKUFUDCPZDW-JYJNAYRXSA-N 0.000 description 2
- IUYCGMNKIZDRQI-BQBZGAKWSA-N Met-Gly-Ala Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O IUYCGMNKIZDRQI-BQBZGAKWSA-N 0.000 description 2
- LQTGGXSOMDSWTQ-UNQGMJICSA-N Met-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCSC)N)O LQTGGXSOMDSWTQ-UNQGMJICSA-N 0.000 description 2
- MUDYEFAKNSTFAI-JYJNAYRXSA-N Met-Tyr-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O MUDYEFAKNSTFAI-JYJNAYRXSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- SEPNOAFMZLLCEW-UBHSHLNASA-N Phe-Ala-Val Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O SEPNOAFMZLLCEW-UBHSHLNASA-N 0.000 description 2
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 2
- RLUMIJXNHJVUCO-JBACZVJFSA-N Phe-Gln-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 RLUMIJXNHJVUCO-JBACZVJFSA-N 0.000 description 2
- PPHFTNABKQRAJV-JYJNAYRXSA-N Phe-His-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PPHFTNABKQRAJV-JYJNAYRXSA-N 0.000 description 2
- DZVXMMSUWWUIQE-ACRUOGEOSA-N Phe-His-Tyr Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N DZVXMMSUWWUIQE-ACRUOGEOSA-N 0.000 description 2
- GPLWGAYGROGDEN-BZSNNMDCSA-N Phe-Phe-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O GPLWGAYGROGDEN-BZSNNMDCSA-N 0.000 description 2
- RVEVENLSADZUMS-IHRRRGAJSA-N Phe-Pro-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O RVEVENLSADZUMS-IHRRRGAJSA-N 0.000 description 2
- AAERWTUHZKLDLC-IHRRRGAJSA-N Phe-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O AAERWTUHZKLDLC-IHRRRGAJSA-N 0.000 description 2
- BPIMVBKDLSBKIJ-FCLVOEFKSA-N Phe-Thr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BPIMVBKDLSBKIJ-FCLVOEFKSA-N 0.000 description 2
- YFXXRYFWJFQAFW-JHYOHUSXSA-N Phe-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O YFXXRYFWJFQAFW-JHYOHUSXSA-N 0.000 description 2
- VGTJSEYTVMAASM-RPTUDFQQSA-N Phe-Thr-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VGTJSEYTVMAASM-RPTUDFQQSA-N 0.000 description 2
- BAONJAHBAUDJKA-BZSNNMDCSA-N Phe-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=CC=C1 BAONJAHBAUDJKA-BZSNNMDCSA-N 0.000 description 2
- MHNBYYFXWDUGBW-RPTUDFQQSA-N Phe-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N)O MHNBYYFXWDUGBW-RPTUDFQQSA-N 0.000 description 2
- KUSYCSMTTHSZOA-DZKIICNBSA-N Phe-Val-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N KUSYCSMTTHSZOA-DZKIICNBSA-N 0.000 description 2
- RGMLUHANLDVMPB-ULQDDVLXSA-N Phe-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RGMLUHANLDVMPB-ULQDDVLXSA-N 0.000 description 2
- MWQXFDIQXIXPMS-UNQGMJICSA-N Phe-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O MWQXFDIQXIXPMS-UNQGMJICSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- DBALDZKOTNSBFM-FXQIFTODSA-N Pro-Ala-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DBALDZKOTNSBFM-FXQIFTODSA-N 0.000 description 2
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 2
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 2
- XUSDDSLCRPUKLP-QXEWZRGKSA-N Pro-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 XUSDDSLCRPUKLP-QXEWZRGKSA-N 0.000 description 2
- SOACYAXADBWDDT-CYDGBPFRSA-N Pro-Ile-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SOACYAXADBWDDT-CYDGBPFRSA-N 0.000 description 2
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 2
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 2
- DSGSTPRKNYHGCL-JYJNAYRXSA-N Pro-Phe-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O DSGSTPRKNYHGCL-JYJNAYRXSA-N 0.000 description 2
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 2
- PKHDJFHFMGQMPS-RCWTZXSCSA-N Pro-Thr-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PKHDJFHFMGQMPS-RCWTZXSCSA-N 0.000 description 2
- CHYAYDLYYIJCKY-OSUNSFLBSA-N Pro-Thr-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CHYAYDLYYIJCKY-OSUNSFLBSA-N 0.000 description 2
- JDJMFMVVJHLWDP-UNQGMJICSA-N Pro-Thr-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JDJMFMVVJHLWDP-UNQGMJICSA-N 0.000 description 2
- BXHRXLMCYSZSIY-STECZYCISA-N Pro-Tyr-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O BXHRXLMCYSZSIY-STECZYCISA-N 0.000 description 2
- OABLKWMLPUGEQK-JYJNAYRXSA-N Pro-Tyr-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(O)=O OABLKWMLPUGEQK-JYJNAYRXSA-N 0.000 description 2
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 2
- MMGJPDWSIOAGTH-ACZMJKKPSA-N Ser-Ala-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MMGJPDWSIOAGTH-ACZMJKKPSA-N 0.000 description 2
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 2
- PZZJMBYSYAKYPK-UWJYBYFXSA-N Ser-Ala-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PZZJMBYSYAKYPK-UWJYBYFXSA-N 0.000 description 2
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 2
- UGJRQLURDVGULT-LKXGYXEUSA-N Ser-Asn-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UGJRQLURDVGULT-LKXGYXEUSA-N 0.000 description 2
- BQWCDDAISCPDQV-XHNCKOQMSA-N Ser-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N)C(=O)O BQWCDDAISCPDQV-XHNCKOQMSA-N 0.000 description 2
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 2
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 2
- ZOPISOXXPQNOCO-SVSWQMSJSA-N Ser-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CO)N ZOPISOXXPQNOCO-SVSWQMSJSA-N 0.000 description 2
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 2
- PMCMLDNPAZUYGI-DCAQKATOSA-N Ser-Lys-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMCMLDNPAZUYGI-DCAQKATOSA-N 0.000 description 2
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 2
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 2
- OZPDGESCTGGNAD-CIUDSAMLSA-N Ser-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO OZPDGESCTGGNAD-CIUDSAMLSA-N 0.000 description 2
- FLMYSKVSDVHLEW-SVSWQMSJSA-N Ser-Thr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLMYSKVSDVHLEW-SVSWQMSJSA-N 0.000 description 2
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 2
- PIQRHJQWEPWFJG-UWJYBYFXSA-N Ser-Tyr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O PIQRHJQWEPWFJG-UWJYBYFXSA-N 0.000 description 2
- ANOQEBQWIAYIMV-AEJSXWLSSA-N Ser-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N ANOQEBQWIAYIMV-AEJSXWLSSA-N 0.000 description 2
- LHUBVKCLOVALIA-HJGDQZAQSA-N Thr-Arg-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LHUBVKCLOVALIA-HJGDQZAQSA-N 0.000 description 2
- JNQZPAWOPBZGIX-RCWTZXSCSA-N Thr-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N JNQZPAWOPBZGIX-RCWTZXSCSA-N 0.000 description 2
- VIBXMCZWVUOZLA-OLHMAJIHSA-N Thr-Asn-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VIBXMCZWVUOZLA-OLHMAJIHSA-N 0.000 description 2
- LXWZOMSOUAMOIA-JIOCBJNQSA-N Thr-Asn-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O LXWZOMSOUAMOIA-JIOCBJNQSA-N 0.000 description 2
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 2
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 2
- JEDIEMIJYSRUBB-FOHZUACHSA-N Thr-Asp-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O JEDIEMIJYSRUBB-FOHZUACHSA-N 0.000 description 2
- VUVCRYXYUUPGSB-GLLZPBPUSA-N Thr-Gln-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O VUVCRYXYUUPGSB-GLLZPBPUSA-N 0.000 description 2
- LAFLAXHTDVNVEL-WDCWCFNPSA-N Thr-Gln-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O LAFLAXHTDVNVEL-WDCWCFNPSA-N 0.000 description 2
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 2
- YSXYEJWDHBCTDJ-DVJZZOLTSA-N Thr-Gly-Trp Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O YSXYEJWDHBCTDJ-DVJZZOLTSA-N 0.000 description 2
- ADPHPKGWVDHWML-PPCPHDFISA-N Thr-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N ADPHPKGWVDHWML-PPCPHDFISA-N 0.000 description 2
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 2
- JMBRNXUOLJFURW-BEAPCOKYSA-N Thr-Phe-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N)O JMBRNXUOLJFURW-BEAPCOKYSA-N 0.000 description 2
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 2
- NHQVWACSJZJCGJ-FLBSBUHZSA-N Thr-Thr-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NHQVWACSJZJCGJ-FLBSBUHZSA-N 0.000 description 2
- CSNBWOJOEOPYIJ-UVOCVTCTSA-N Thr-Thr-Lys Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O CSNBWOJOEOPYIJ-UVOCVTCTSA-N 0.000 description 2
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 2
- GRIUMVXCJDKVPI-IZPVPAKOSA-N Thr-Thr-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GRIUMVXCJDKVPI-IZPVPAKOSA-N 0.000 description 2
- KHTIUAKJRUIEMA-HOUAVDHOSA-N Thr-Trp-Asp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 KHTIUAKJRUIEMA-HOUAVDHOSA-N 0.000 description 2
- VMSSYINFMOFLJM-KJEVXHAQSA-N Thr-Tyr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCSC)C(=O)O)N)O VMSSYINFMOFLJM-KJEVXHAQSA-N 0.000 description 2
- SAKLWFSRZTZQAJ-GQGQLFGLSA-N Trp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SAKLWFSRZTZQAJ-GQGQLFGLSA-N 0.000 description 2
- PKZIWSHDJYIPRH-JBACZVJFSA-N Trp-Tyr-Gln Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKZIWSHDJYIPRH-JBACZVJFSA-N 0.000 description 2
- NOXKHHXSHQFSGJ-FQPOAREZSA-N Tyr-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NOXKHHXSHQFSGJ-FQPOAREZSA-N 0.000 description 2
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 2
- PDKILSUYSUGCAO-JBACZVJFSA-N Tyr-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)O)N PDKILSUYSUGCAO-JBACZVJFSA-N 0.000 description 2
- HHFMNAVFGBYSAT-IGISWZIWSA-N Tyr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N HHFMNAVFGBYSAT-IGISWZIWSA-N 0.000 description 2
- KHCSOLAHNLOXJR-BZSNNMDCSA-N Tyr-Leu-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHCSOLAHNLOXJR-BZSNNMDCSA-N 0.000 description 2
- HSBZWINKRYZCSQ-KKUMJFAQSA-N Tyr-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O HSBZWINKRYZCSQ-KKUMJFAQSA-N 0.000 description 2
- NKMFRGPKTIEXSK-ULQDDVLXSA-N Tyr-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NKMFRGPKTIEXSK-ULQDDVLXSA-N 0.000 description 2
- KZOZXAYPVKKDIO-UFYCRDLUSA-N Tyr-Met-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 KZOZXAYPVKKDIO-UFYCRDLUSA-N 0.000 description 2
- LVILBTSHPTWDGE-PMVMPFDFSA-N Tyr-Trp-Lys Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=C(O)C=C1 LVILBTSHPTWDGE-PMVMPFDFSA-N 0.000 description 2
- KSGKJSFPWSMJHK-JNPHEJMOSA-N Tyr-Tyr-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KSGKJSFPWSMJHK-JNPHEJMOSA-N 0.000 description 2
- HZWPGKAKGYJWCI-ULQDDVLXSA-N Tyr-Val-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O HZWPGKAKGYJWCI-ULQDDVLXSA-N 0.000 description 2
- 108010064997 VPY tripeptide Proteins 0.000 description 2
- IZFVRRYRMQFVGX-NRPADANISA-N Val-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N IZFVRRYRMQFVGX-NRPADANISA-N 0.000 description 2
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 2
- BEGDZYNDCNEGJZ-XVKPBYJWSA-N Val-Gly-Gln Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O BEGDZYNDCNEGJZ-XVKPBYJWSA-N 0.000 description 2
- JZWZACGUZVCQPS-RNJOBUHISA-N Val-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N JZWZACGUZVCQPS-RNJOBUHISA-N 0.000 description 2
- MYLNLEIZWHVENT-VKOGCVSHSA-N Val-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](C(C)C)N MYLNLEIZWHVENT-VKOGCVSHSA-N 0.000 description 2
- DJQIUOKSNRBTSV-CYDGBPFRSA-N Val-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](C(C)C)N DJQIUOKSNRBTSV-CYDGBPFRSA-N 0.000 description 2
- FEXILLGKGGTLRI-NHCYSSNCSA-N Val-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N FEXILLGKGGTLRI-NHCYSSNCSA-N 0.000 description 2
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 2
- YTNGABPUXFEOGU-SRVKXCTJSA-N Val-Pro-Arg Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTNGABPUXFEOGU-SRVKXCTJSA-N 0.000 description 2
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 2
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 2
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 2
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 2
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 2
- PQSNETRGCRUOGP-KKHAAJSZSA-N Val-Thr-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O PQSNETRGCRUOGP-KKHAAJSZSA-N 0.000 description 2
- UQMPYVLTQCGRSK-IFFSRLJSSA-N Val-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N)O UQMPYVLTQCGRSK-IFFSRLJSSA-N 0.000 description 2
- LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 2
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 2
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 2
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 2
- JSOXWWFKRJKTMT-WOPDTQHZSA-N Val-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N JSOXWWFKRJKTMT-WOPDTQHZSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 108010081404 acein-2 Proteins 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010036533 arginylvaline Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 210000000234 capsid Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 108010054812 diprotin A Proteins 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940031551 inactivated vaccine Drugs 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 108010027338 isoleucylcysteine Proteins 0.000 description 2
- 108010047926 leucyl-lysyl-tyrosine Proteins 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108010054155 lysyllysine Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 2
- 108010024607 phenylalanylalanine Proteins 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 108010079317 prolyl-tyrosine Proteins 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 108010044292 tryptophyltyrosine Proteins 0.000 description 2
- 108010078580 tyrosylleucine Proteins 0.000 description 2
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 1
- FBHOPGDGELNWRH-DRZSPHRISA-N Ala-Glu-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FBHOPGDGELNWRH-DRZSPHRISA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 1
- RNHKOQHGYMTHFR-UBHSHLNASA-N Ala-Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 RNHKOQHGYMTHFR-UBHSHLNASA-N 0.000 description 1
- YYAVDNKUWLAFCV-ACZMJKKPSA-N Ala-Ser-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYAVDNKUWLAFCV-ACZMJKKPSA-N 0.000 description 1
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- NONSEUUPKITYQT-BQBZGAKWSA-N Arg-Asn-Gly Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N)CN=C(N)N NONSEUUPKITYQT-BQBZGAKWSA-N 0.000 description 1
- RWCLSUOSKWTXLA-FXQIFTODSA-N Arg-Asp-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RWCLSUOSKWTXLA-FXQIFTODSA-N 0.000 description 1
- YTMKMRSYXHBGER-IHRRRGAJSA-N Arg-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YTMKMRSYXHBGER-IHRRRGAJSA-N 0.000 description 1
- OWSMKCJUBAPHED-JYJNAYRXSA-N Arg-Pro-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OWSMKCJUBAPHED-JYJNAYRXSA-N 0.000 description 1
- FRBAHXABMQXSJQ-FXQIFTODSA-N Arg-Ser-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FRBAHXABMQXSJQ-FXQIFTODSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DXZNJWFECGJCQR-FXQIFTODSA-N Asn-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N DXZNJWFECGJCQR-FXQIFTODSA-N 0.000 description 1
- JGIAYNNXZKKKOW-KKUMJFAQSA-N Asn-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N JGIAYNNXZKKKOW-KKUMJFAQSA-N 0.000 description 1
- KSGAFDTYQPKUAP-GMOBBJLQSA-N Asn-Met-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KSGAFDTYQPKUAP-GMOBBJLQSA-N 0.000 description 1
- ZJIFRAPZHAGLGR-MELADBBJSA-N Asn-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZJIFRAPZHAGLGR-MELADBBJSA-N 0.000 description 1
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 1
- YHXNKGKUDJCAHB-PBCZWWQYSA-N Asn-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O YHXNKGKUDJCAHB-PBCZWWQYSA-N 0.000 description 1
- SKQTXVZTCGSRJS-SRVKXCTJSA-N Asn-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O SKQTXVZTCGSRJS-SRVKXCTJSA-N 0.000 description 1
- MYRLSKYSMXNLLA-LAEOZQHASA-N Asn-Val-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MYRLSKYSMXNLLA-LAEOZQHASA-N 0.000 description 1
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 1
- FAEIQWHBRBWUBN-FXQIFTODSA-N Asp-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N FAEIQWHBRBWUBN-FXQIFTODSA-N 0.000 description 1
- HOQGTAIGQSDCHR-SRVKXCTJSA-N Asp-Asn-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HOQGTAIGQSDCHR-SRVKXCTJSA-N 0.000 description 1
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- PGUYEUCYVNZGGV-QWRGUYRKSA-N Asp-Gly-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PGUYEUCYVNZGGV-QWRGUYRKSA-N 0.000 description 1
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 1
- RSMZEHCMIOKNMW-GSSVUCPTSA-N Asp-Thr-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RSMZEHCMIOKNMW-GSSVUCPTSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010061438 CTTAAG-specific type II deoxyribonucleases Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001429382 Coxsackievirus A16 Species 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JSYULGSPLTZDHM-NRPADANISA-N Gln-Ala-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O JSYULGSPLTZDHM-NRPADANISA-N 0.000 description 1
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 1
- SBHVGKBYOQKAEA-SDDRHHMPSA-N Gln-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N)C(=O)O SBHVGKBYOQKAEA-SDDRHHMPSA-N 0.000 description 1
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 1
- XZUUUKNKNWVPHQ-JYJNAYRXSA-N Gln-Phe-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O XZUUUKNKNWVPHQ-JYJNAYRXSA-N 0.000 description 1
- DCWNCMRZIZSZBL-KKUMJFAQSA-N Gln-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)N)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O DCWNCMRZIZSZBL-KKUMJFAQSA-N 0.000 description 1
- CVRUVYDNRPSKBM-QEJZJMRPSA-N Gln-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N CVRUVYDNRPSKBM-QEJZJMRPSA-N 0.000 description 1
- FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 1
- LJLPOZGRPLORTF-CIUDSAMLSA-N Glu-Asn-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O LJLPOZGRPLORTF-CIUDSAMLSA-N 0.000 description 1
- LZMQSTPFYJLVJB-GUBZILKMSA-N Glu-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N LZMQSTPFYJLVJB-GUBZILKMSA-N 0.000 description 1
- ITVBKCZZLJUUHI-HTUGSXCWSA-N Glu-Phe-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ITVBKCZZLJUUHI-HTUGSXCWSA-N 0.000 description 1
- UMZHHILWZBFPGL-LOKLDPHHSA-N Glu-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O UMZHHILWZBFPGL-LOKLDPHHSA-N 0.000 description 1
- CAQXJMUDOLSBPF-SUSMZKCASA-N Glu-Thr-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAQXJMUDOLSBPF-SUSMZKCASA-N 0.000 description 1
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 1
- CLODWIOAKCSBAN-BQBZGAKWSA-N Gly-Arg-Asp Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O CLODWIOAKCSBAN-BQBZGAKWSA-N 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 1
- LXXLEUBUOMCAMR-NKWVEPMBSA-N Gly-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)CN)C(=O)O LXXLEUBUOMCAMR-NKWVEPMBSA-N 0.000 description 1
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 1
- VDCRBJACQKOSMS-JSGCOSHPSA-N Gly-Phe-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O VDCRBJACQKOSMS-JSGCOSHPSA-N 0.000 description 1
- ISSDODCYBOWWIP-GJZGRUSLSA-N Gly-Pro-Trp Chemical compound [H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ISSDODCYBOWWIP-GJZGRUSLSA-N 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- VOEGKUNRHYKYSU-XVYDVKMFSA-N His-Asp-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O VOEGKUNRHYKYSU-XVYDVKMFSA-N 0.000 description 1
- SGLXGEDPYJPGIQ-ACRUOGEOSA-N His-Phe-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N SGLXGEDPYJPGIQ-ACRUOGEOSA-N 0.000 description 1
- PYNPBMCLAKTHJL-SRVKXCTJSA-N His-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O PYNPBMCLAKTHJL-SRVKXCTJSA-N 0.000 description 1
- 241001207270 Human enterovirus Species 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- HUWYGQOISIJNMK-SIGLWIIPSA-N Ile-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HUWYGQOISIJNMK-SIGLWIIPSA-N 0.000 description 1
- PNTWNAXGBOZMBO-MNXVOIDGSA-N Ile-Lys-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PNTWNAXGBOZMBO-MNXVOIDGSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- IIKJNQWOQIWWMR-CIUDSAMLSA-N Leu-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)N IIKJNQWOQIWWMR-CIUDSAMLSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- ZFNLIDNJUWNIJL-WDCWCFNPSA-N Leu-Glu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZFNLIDNJUWNIJL-WDCWCFNPSA-N 0.000 description 1
- FMEICTQWUKNAGC-YUMQZZPRSA-N Leu-Gly-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O FMEICTQWUKNAGC-YUMQZZPRSA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- HQVDJTYKCMIWJP-YUMQZZPRSA-N Lys-Asn-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HQVDJTYKCMIWJP-YUMQZZPRSA-N 0.000 description 1
- YVSHZSUKQHNDHD-KKUMJFAQSA-N Lys-Asn-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N YVSHZSUKQHNDHD-KKUMJFAQSA-N 0.000 description 1
- ONPDTSFZAIWMDI-AVGNSLFASA-N Lys-Leu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ONPDTSFZAIWMDI-AVGNSLFASA-N 0.000 description 1
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 1
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 1
- LOGFVTREOLYCPF-RHYQMDGZSA-N Lys-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-RHYQMDGZSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- HUKLXYYPZWPXCC-KZVJFYERSA-N Met-Ala-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HUKLXYYPZWPXCC-KZVJFYERSA-N 0.000 description 1
- ACYHZNZHIZWLQF-BQBZGAKWSA-N Met-Asn-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O ACYHZNZHIZWLQF-BQBZGAKWSA-N 0.000 description 1
- JPCHYAUKOUGOIB-HJGDQZAQSA-N Met-Glu-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPCHYAUKOUGOIB-HJGDQZAQSA-N 0.000 description 1
- DGNZGCQSVGGYJS-BQBZGAKWSA-N Met-Gly-Asp Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O DGNZGCQSVGGYJS-BQBZGAKWSA-N 0.000 description 1
- SLQDSYZHHOKQSR-QXEWZRGKSA-N Met-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCSC SLQDSYZHHOKQSR-QXEWZRGKSA-N 0.000 description 1
- LQMHZERGCQJKAH-STQMWFEESA-N Met-Gly-Phe Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 LQMHZERGCQJKAH-STQMWFEESA-N 0.000 description 1
- SXWQMBGNFXAGAT-FJXKBIBVSA-N Met-Gly-Thr Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SXWQMBGNFXAGAT-FJXKBIBVSA-N 0.000 description 1
- ZIIMORLEZLVRIP-SRVKXCTJSA-N Met-Leu-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZIIMORLEZLVRIP-SRVKXCTJSA-N 0.000 description 1
- HSJIGJRZYUADSS-IHRRRGAJSA-N Met-Lys-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HSJIGJRZYUADSS-IHRRRGAJSA-N 0.000 description 1
- JOYFULUKJRJCSX-IUCAKERBSA-N Met-Met-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O JOYFULUKJRJCSX-IUCAKERBSA-N 0.000 description 1
- PHURAEXVWLDIGT-LPEHRKFASA-N Met-Ser-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N PHURAEXVWLDIGT-LPEHRKFASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 1
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 1
- FQUUYTNBMIBOHS-IHRRRGAJSA-N Phe-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N FQUUYTNBMIBOHS-IHRRRGAJSA-N 0.000 description 1
- WEDZFLRYSIDIRX-IHRRRGAJSA-N Phe-Ser-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 WEDZFLRYSIDIRX-IHRRRGAJSA-N 0.000 description 1
- SHUFSZDAIPLZLF-BEAPCOKYSA-N Phe-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)O SHUFSZDAIPLZLF-BEAPCOKYSA-N 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 1
- WWAQEUOYCYMGHB-FXQIFTODSA-N Pro-Asn-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 WWAQEUOYCYMGHB-FXQIFTODSA-N 0.000 description 1
- MLQVJYMFASXBGZ-IHRRRGAJSA-N Pro-Asn-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O MLQVJYMFASXBGZ-IHRRRGAJSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- GNFHQWNCSSPOBT-ULQDDVLXSA-N Pro-Trp-Gln Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCC(=O)N)C(=O)O GNFHQWNCSSPOBT-ULQDDVLXSA-N 0.000 description 1
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 1
- IMNVAOPEMFDAQD-NHCYSSNCSA-N Pro-Val-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IMNVAOPEMFDAQD-NHCYSSNCSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 1
- XVAUJOAYHWWNQF-ZLUOBGJFSA-N Ser-Asn-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O XVAUJOAYHWWNQF-ZLUOBGJFSA-N 0.000 description 1
- OJPHFSOMBZKQKQ-GUBZILKMSA-N Ser-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO OJPHFSOMBZKQKQ-GUBZILKMSA-N 0.000 description 1
- JIPVNVNKXJLFJF-BJDJZHNGSA-N Ser-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N JIPVNVNKXJLFJF-BJDJZHNGSA-N 0.000 description 1
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 1
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 1
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 1
- JMQUAZXYFAEOIH-XGEHTFHBSA-N Thr-Arg-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N)O JMQUAZXYFAEOIH-XGEHTFHBSA-N 0.000 description 1
- OJRNZRROAIAHDL-LKXGYXEUSA-N Thr-Asn-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OJRNZRROAIAHDL-LKXGYXEUSA-N 0.000 description 1
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 1
- UDNVOQMPQBEITB-MEYUZBJRSA-N Thr-His-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O UDNVOQMPQBEITB-MEYUZBJRSA-N 0.000 description 1
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 1
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 1
- GVMXJJAJLIEASL-ZJDVBMNYSA-N Thr-Pro-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O GVMXJJAJLIEASL-ZJDVBMNYSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- DVAAUUVLDFKTAQ-VHWLVUOQSA-N Trp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N DVAAUUVLDFKTAQ-VHWLVUOQSA-N 0.000 description 1
- UJGDFQRPYGJBEH-AAEUAGOBSA-N Trp-Ser-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N UJGDFQRPYGJBEH-AAEUAGOBSA-N 0.000 description 1
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 1
- KCPFDGNYAMKZQP-KBPBESRZSA-N Tyr-Gly-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O KCPFDGNYAMKZQP-KBPBESRZSA-N 0.000 description 1
- OFHKXNKJXURPSY-ULQDDVLXSA-N Tyr-Met-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O OFHKXNKJXURPSY-ULQDDVLXSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LNYOXPDEIZJDEI-NHCYSSNCSA-N Val-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LNYOXPDEIZJDEI-NHCYSSNCSA-N 0.000 description 1
- DDNIHOWRDOXXPF-NGZCFLSTSA-N Val-Asp-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DDNIHOWRDOXXPF-NGZCFLSTSA-N 0.000 description 1
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 1
- ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 1
- MJOUSKQHAIARKI-JYJNAYRXSA-N Val-Phe-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 MJOUSKQHAIARKI-JYJNAYRXSA-N 0.000 description 1
- XBJKAZATRJBDCU-GUBZILKMSA-N Val-Pro-Ala Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O XBJKAZATRJBDCU-GUBZILKMSA-N 0.000 description 1
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 1
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940028617 conventional vaccine Drugs 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108010085203 methionylmethionine Proteins 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明涉及医药领域,特别是涉及重组柯萨奇病毒A10病毒样颗粒及其用途,所述重组柯萨奇病毒A10病毒样颗粒由基因组中整合有编码柯萨奇病毒A10的VP0、VP3和VP1衣壳蛋白的细胞系产生。本发明还提供所述重组柯萨奇病毒A10病毒样颗粒在制备预防手足口病产品中的用途。所述预防手足口病产品为药物组合物,例如为疫苗组合物。在免疫原性研究中发现本发明的柯萨奇病毒A10VLP可在小鼠体内诱导良好的免疫反应,提示该VLP可作为柯萨奇病毒A10的候选疫苗。
Description
技术领域
本发明涉及医药领域,特别是涉及重组柯萨奇病毒A10病毒样颗粒及其用途。
背景技术
手足口病是一种5岁以下儿童常见的婴幼儿传染病,主要临床表现为手、足和口等部位出现小疱疹或小溃疡,少数患儿可引起肺水肿、无菌性脑膜脑炎、心肌炎等一系列并发症甚至导致死亡。手足口病是由人肠道病毒属的柯萨奇病毒A组16、4、5、7、9、10,B组2、5型以及肠道病毒71型和埃可病毒30感染引起的,其中肠道病毒71和柯萨奇病毒A16是导致手足口病暴发的主要病原体。近年来由柯萨奇病毒A6和A10感染的报道越来越常见。目前尚无针对柯萨奇病毒A10的特异性药物,因此疫苗就成为预防柯萨奇病毒A10感染的最有效的方法。应用传统的灭活疫苗的方法开发柯萨奇病毒A10疫苗已经有学者进行过研究并且可以诱导小鼠产生良好的免疫反应。不过灭活疫苗存在表位破坏,灭活不充分以及成本高等问题。
柯萨奇病毒A10属于小RNA病毒科肠道病毒属,为无包膜的二十面立体对称球形颗粒,直径约30nm,其基因组是单股正链RNA,两端为保守的非编码区,中间为一个开放阅读框的编码区,此编码区编码结构蛋白P1和非结构蛋白P2与P3,其中P1可被蛋白酶3CD切割为衣壳蛋白VP0、VP3和VP1,并组装成病毒的衣壳。这些衣壳蛋白与病毒RNA可进一步组装为真病毒,并伴随着VP0切割为VP4和VP2。据报道,柯萨奇病毒A10灭活病毒可以诱导小鼠产生良好的免疫反应,不过灭活疫苗存在表位破坏、灭活不充分以及成本高等问题。病毒样颗粒(Virus-like particle,VLP)与病毒在形态与组成上相似,可诱导较好的免疫反应,为柯萨奇病毒A10疫苗的开发提供了一种方案。研究表明,共表达柯萨奇病毒A10结构蛋白P1和3CD后可切割为VP0、VP3和VP1衣壳蛋白,并进一步组装成柯萨奇病毒A10 VLP,且该VLP可以保护小鼠免受柯萨奇病毒A10致死性攻击。但通过共表达P1和3CD获取的VLP,可能存在P1的不完全切割;此外,VP1衣壳蛋白易发生降解,这些均会影响VLP组成的一致性,这对产品的质量控制造成较大的潜在风险。
发明内容
鉴于以上所述现有技术的缺点,本发明的目的在于提供重组柯萨奇病毒A10病毒样颗粒及其用途,用于解决现有技术中的问题。
为实现上述目的及其他相关目的,本发明提供多核苷酸,所述多核苷酸包括编码柯萨奇病毒A10的VP0、VP1和VP3衣壳蛋白的核苷酸,所述多核苷酸不包括RBS序列和编码柯萨奇病毒A10其他衣壳蛋白的核苷酸。
本发明还提供一种核酸构建体,所述核酸构建体包括所述多核苷酸。
本发明还提供一种细胞系,所述细胞系中包括所述核酸构建体,或基因组中整合有所述多核苷酸。
本发明还提供一种重组柯萨奇病毒A10病毒样颗粒,所述重组柯萨奇病毒A10病毒样颗粒包括VP0、VP3和VP1衣壳蛋白,不包括柯萨奇病毒A10其他衣壳蛋白。
本发明还提供所述重组柯萨奇病毒A10病毒样颗粒在制备预防手足口病产品中的用途。
本发明还提供一种用于预防手足口病的药物组合物,所述药物组合物包括所述重组柯萨奇病毒A10病毒样颗粒和药学上可接受的载体。
如上所述,本发明的重组柯萨奇病毒A10病毒样颗粒及其用途,具有以下有益效果:病毒样颗粒与病毒在形态与组成上相似,免疫原性研究发现柯萨奇病毒A10VLP可在小鼠体内诱导良好的中和抗体水平,即可诱导较好的免疫反应,为柯萨奇病毒A10疫苗的开发提供了解决方案,该VLP可作为柯萨奇病毒A10的候选疫苗,为预防柯萨奇病毒A10感染提供有效方法。
附图说明
图1显示为本发明的pPink/HC-A10 VP031表达质粒的表达框示意图,PAOX1为AOX1启动子,CYC1 TT为CYC1终止子,VP0、VP3和VP1为柯萨奇病毒A10衣壳蛋白序列。
图2显示为SDS-PAGE分析柯萨奇病毒A10 VLP,其中(A)为A10 VLP-full的SDS-PAGE分析,(B)为A10 VLP-N50的SDS-PAGE分析,(C)为A10 VLP-N72的SDS-PAGE分析。
图3显示为柯萨奇病毒A10 VLP的粒径分析图,其中(A)为A10 VLP-full的动态光散射分析,(B)为A10 VLP-N50的动态光散射分析,(C)为A10 VLP-N72的动态光散射分析。
图4显示柯萨奇病毒A10 VLP免疫血清特异抗体滴度,其中(A)第二次免疫后血清滴度(A10 VLP-full、A10 VLP-N50及A10 VLP-N72免疫原性比较);(B)为第三次免疫后血清滴度(A10 VLP-full、A10 VLP-N50及A10 VLP-N72免疫原性比较)。为了方便统计,将OD450nm吸光值大于0.15的最高稀释倍数的倒数定位该样品的特异抗体滴度,横线显示为几何平均值。
具体实施方式
为避免结构蛋白P1的不完全切割,本发明构建了含有柯萨奇病毒A10 VP0、VP3和VP1三个串联表达框的毕赤酵母表达菌株,并成功纯化了VLP-full。为了解决VP1的降解问题,本发明在串联表达柯萨奇病毒A10 VP0、VP3和VP1的基础上,对VP1 N端进行50个和72个氨基酸的截短,并获得了毕赤酵母表达菌株和纯化后的VLP-N50和VLP-N72。SDS-PAGE显示VLP-N50和VLP-N72的VP1均无明显降解,且免疫小鼠发现不论VLP-N50还是VLP-N72诱导的免疫水平均与VLP-full相当。因此,经串联表达衣壳蛋白VP0、VP3和截短VP1获得的柯萨奇病毒A10 VLP不仅解决了P1不完全切割和VP1降解的组成均一性问题,同时兼具良好的免疫原性,为柯萨奇疫病毒A10疫苗的研发提供了新思路。
基于以上,本发明提供一种多核苷酸,所述多核苷酸包括编码柯萨奇病毒A10的VP0、VP3和VP1衣壳蛋白的核苷酸,不包括RBS序列和编码柯萨奇病毒A10其他衣壳蛋白的核苷酸。
如图1所示,所述多核苷酸包括编码柯萨奇病毒A10的VP0、VP3和VP1衣壳蛋白的的核苷酸排列顺序为:VP0-VP3-VP1。
所述多核苷酸中表达各衣壳蛋白的表达框在所述多核苷酸中串联。
在如图1所示的实施例中,具体的串联方式为启动子-VP0-终止子-启动子-VP3-终止子-启动子-VP1-终止子。当然,在其他实施方式中,三个表达框的串联方式也可以是以下中的任一种:启动子-VP0-终止子-启动子-VP1-终止子-启动子-VP3-终止子、启动子-VP3-终止子-启动子-VP0-终止子-启动子-VP1-终止子、启动子-VP3-终止子-启动子-VP1-终止子-启动子-VP0-终止子、启动子-VP1-终止子-启动子-VP3-终止子-启动子-VP0-终止子、启动子-VP1-终止子-启动子-VP0-终止子-启动子-VP3-终止子。在一种实施方式中,所述启动子为AOX1启动子,所述终止子为CYC1终止子。由于各蛋白均为独立的开放阅读框,因此不同的串联方式均能达到与实施例相同的效果。
所述编码柯萨奇病毒A10的VP0衣壳蛋白的核苷酸为VP0全长核苷酸序列或截短的核苷酸,所述编码柯萨奇病毒VP1衣壳蛋白的核苷酸为VP1全长核苷酸序列或截短的核苷酸,所述编码柯萨奇病毒VP3衣壳蛋白的核苷酸为编码柯萨奇病毒A10的VP3衣壳蛋白的全长核苷酸序列或截短的核苷酸序列。
在一种实施方式中,所述截短的核苷酸可以是VP1截短0-216个核苷酸,VP0截短0-243个核苷酸,VP3截短0-171个核苷酸。
在一种实施方式中,所述多核苷酸编码的柯萨奇病毒A10的VP1衣壳蛋白为截短45-75个氨基酸的VP1衣壳蛋白。优选的,为截短50~72个氨基酸。具体的,例如为以下中的任一:截短45~50个氨基酸、截短50~55个氨基酸、截短55~60个氨基酸、截短60~65个氨基酸、截短65~70个氨基酸、截短70~72个氨基酸、截短72~75个氨基酸。
在一种实施方式中,编码柯萨奇病毒A10的VP0衣壳蛋白的核苷酸序列如SEQ IDNO:8所示。编码柯萨奇病毒A10的VP3衣壳蛋白的核苷酸序列如SEQ ID NO:9所示。编码柯萨奇病毒A10的VP1衣壳蛋白的核苷酸序列如SEQ ID NO:10或SEQ ID NO:11或SEQ ID NO:12所示。
在一种实施方式中,与SEQ ID NO.8~12所示序列的同源性在95%以上的序列,或与SEQ ID NO.8~12所示序列互补的序列也能达到与本发明实施例相同的效果。
所述多核苷酸中不包括编码P1、3CD蛋白的核苷酸。
所述多核苷酸的序列为经过密码子优化后得到的序列。
在一种实施方式中,所述编码柯萨奇病毒A10的VP0衣壳蛋白的核苷酸编码氨基酸序列如SEQ ID NO:3所示的VP0衣壳蛋白;所述编码柯萨奇病毒A10的VP3衣壳蛋白的核苷酸编码氨基酸序列如SEQ ID NO:4所示的VP3衣壳蛋白;所述编码柯萨奇病毒A10的VP1衣壳蛋白的核苷酸编码氨基酸序列如SEQ ID NO:5或SEQ ID NO:6或SEQ ID NO:7所示的VP1衣壳蛋白。
在一种实施方式中,所述柯萨奇病毒A10的VP1衣壳蛋白的氨基酸序列选自以下任一项:1)如SEQ ID NO:5或SEQ ID NO:6或SEQ ID NO:7所示的序列;2)与SEQ ID NO:5或SEQID NO:6或SEQ ID NO:7所示序列的同源性在95%、96%、97%、98%或99%以上的序列;3)与前两项任一所述的序列互补的序列。
本发明还提供一种核酸构建体,所述核酸构建体包括所述多核苷酸。
术语“核酸构建体”是指可以被引入靶细胞或组织中的人工构建的核酸区段,所述核酸构建体包括载体骨架即表达载体与表达框,所述核酸构建体可以为质粒。
所述核酸构建体中VP0、VP3和VP1表达框可以是各自独立的单拷贝或多拷贝。较佳的,所述核酸构建体中VP0、VP3和VP1表达框均为单拷贝。
所述核酸构建体中除包括所述多核苷酸中所含的柯萨奇病毒A10的衣壳蛋白核苷酸外,不包括编码柯萨奇病毒A10其他衣壳蛋白的核苷酸。
在一种实施方式中,所述核酸构建体还包括表达载体。所述表达载体可以是现有技术中任意适于表达柯萨奇病毒的表达载体,例如为酵母表达载体。较佳的为毕赤酵母表达载体pPink-HC(厂家:Invitrogen)。
在一种实施方式中,所述核酸构建体核苷酸序列如SEQ ID NO:13、SEQ ID NO:14或SEQ ID NO:15所示。
本发明还提供一种细胞系,所述细胞系中包括所述核酸构建体,或基因组中整合有所述多核苷酸。
所述细胞系为真核细胞。在一种实施方式中,所述细胞系为将所述核酸构建体转导入毕赤酵母细胞得到。
本发明还提供一种重组柯萨奇病毒A10病毒样颗粒,所述重组柯萨奇病毒A10病毒样颗粒包括VP0、VP3和VP1衣壳蛋白,不包括柯萨奇病毒A10其他衣壳蛋白。
所述重组柯萨奇病毒A10病毒样颗粒由所述细胞系产生。
重组柯萨奇病毒A10病毒样颗粒的水合直径为35nm~45nm。所述重组柯萨奇病毒A10病毒样颗粒的大小均一。
本发明还提供所述重组柯萨奇病毒A10病毒样颗粒的制备方法,所述制备方法包括如下步骤:
1)培养所述细胞系,使其表达重组柯萨奇病毒A10病毒样颗粒;
2)分离出所述细胞系表达的重组柯萨奇病毒A10病毒样颗粒。
在一种实施方式中,培养所述细胞系的条件为28℃-30℃,250-300rpm。
在一种实施方式中,所述细胞系通过将所述核酸构建体转导入宿主细胞得到。在一种实施方式中,所述宿主细胞为毕赤酵母细胞。
在一种实施方式中,所述核酸构建体的制备方法包括如下步骤:
1)将密码子优化后的表达柯萨奇病毒A10衣壳蛋白的核苷酸分别克隆入不同的表达载体中,获得中间构建体;
2)将步骤1)获得的中间构建体重组后获得所述核酸构建体。
本发明还提供所述重组柯萨奇病毒A10病毒样颗粒在制备预防手足口病产品中的用途。
在一种实施方式中,所述手足口病为柯萨奇病毒A10感染的手足口病。
所述预防手足口病产品为药物组合物。所述药物组合物例如为疫苗组合物。
本发明还提供一种用于预防手足口病的药物组合物,所述药物组合物包括所述重组柯萨奇病毒A10病毒样颗粒和药学上可接受的载体。
所述药物组合物可以是单价的(仅含有一种病毒样颗粒),也可以是多价的(含有多种病毒样颗粒)。
所述药物组合物可制备成各种常规剂型,例如:注射剂、粒剂、片剂、丸剂、栓剂、胶囊、悬浮液、喷雾剂等。
所述药物组合物包括预防或治疗有效量的本发明病毒样颗粒或多核苷酸。
术语“预防或治疗有效量”指药物组合物治疗、缓解或预防目标疾病或状况的量,或是表现出可检测的治疗或预防效果的量。即病毒样颗粒的量在所选用的给药路径中足以引发免疫应答,能有效促使保护宿主抵抗相关的疾病。该效果可通过例如抗原水平来检测。治疗效果也包括生理性症状的减少。对于某一对象的精确有效量取决于该对象的体型和健康状况、病症的性质和程度、以及选择给予的治疗剂和/或治疗剂的组合。因此,预先指定准确的有效量是没用的。然而,对于某给定的状况而言,可以用常规实验来确定该有效量。
在一种实施方式中,为了本发明的目的,有效的剂量为给予个体约0.001毫克/千克至1000毫克/千克,较佳地约0.01毫克/千克至100毫克/千克体重的病毒样颗粒。
药物组合物还可含有药学上可接受的载体。术语“药学上可接受的载体”指用于药物组合物(例如本发明的重组病毒样颗粒)给药的载体。该术语指这样一些药剂载体:它们本身不诱导产生对接受该组合物的个体有害的抗体,且给药后没有过分的毒性。合适的载体可以是大的、代谢缓慢的大分子,如蛋白质、多糖、聚乳酸(polylactic acid)、聚乙醇酸等。这些载体是本领域普通技术人员所熟知的。药学上可接受的载体可包括液体,如水、盐水、甘油和乙醇。另外,这些载体中还可能存在辅助性的物质,如润湿剂或乳化剂、pH缓冲物质等。通常,可将组合物制成可注射剂,例如液体溶液或悬液;还可制成在注射前适合配入溶液或悬液、液体赋形剂的固体形式。脂质体也包括在药学上可接受的载体的定义中。
一旦配成本发明的组合物,可将其直接给予对象。待治疗的对象可以是哺乳动物,尤其是人。
所述药物组合物例如为疫苗组合物。疫苗组合物可用已知的方法将本发明的病毒样颗粒直接施用于个体。通常采用与常规疫苗相同的施用途径和/或模拟病原体感染路径施用这些疫苗。
给予本发明药物组合物的途径包括:肌内、皮下、皮内、肺内、静脉内、经鼻、经口服或其它肠胃外给药途径。如果需要,可以组合给药途径,或根据疾病情况进行调节。疫苗组合物可以单剂量或多剂量给予,且可以包括给予加强剂量以引发和/或维持免疫力。
以下通过特定的具体实例说明本发明的实施方式,本领域技术人员可由本说明书所揭露的内容轻易地了解本发明的其他优点与功效。本发明还可以通过另外不同的具体实施方式加以实施或应用,本说明书中的各项细节也可以基于不同观点与应用,在没有背离本发明的精神下进行各种修饰或改变。
在进一步描述本发明具体实施方式之前,应理解,本发明的保护范围不局限于下述特定的具体实施方案;还应当理解,本发明实施例中使用的术语是为了描述特定的具体实施方案,而不是为了限制本发明的保护范围;在本发明说明书和权利要求书中,除非文中另外明确指出,单数形式“一个”、“一”和“这个”包括复数形式。
当实施例给出数值范围时,应理解,除非本发明另有说明,每个数值范围的两个端点以及两个端点之间任何一个数值均可选用。除非另外定义,本发明中使用的所有技术和科学术语与本技术领域技术人员通常理解的意义相同。除实施例中使用的具体方法、设备、材料外,根据本技术领域的技术人员对现有技术的掌握及本发明的记载,还可以使用与本发明实施例中所述的方法、设备、材料相似或等同的现有技术的任何方法、设备和材料来实现本发明。
实施例中利用毕赤酵母串联表达柯萨奇病毒A10的VP0、VP3和不同程度N端氨基酸截短的VP1(N50和N72)衣壳蛋白,获得了成功组装的柯萨奇病毒A10 VLP-N50和A10 VLP-N72,这两种VLP不存在P1不完全切割的问题且VP1无明显降解,解决了柯萨奇病毒A10 VLP组成均一性及可能潜在的安全性问题;进一步的免疫原性研究发现A10 VLP-N50和A10 VLP-N72均可在小鼠体内诱导良好的抗体水平,提示这两种VLP可作为柯萨奇病毒A10的候选疫苗。
实施例1柯萨奇病毒A10表达质粒构建
为了使表达达到最优,将柯萨奇病毒A10结构蛋白P1氨基酸序列根据毕赤酵母密码子偏好性进行优化合成。利用EcoRⅠ和KpnⅠ位点连入pPinK-HC质粒中,得到质粒pPink/HC-A10 P1。柯萨奇病毒A10结构蛋白P1氨基酸序列如SEQ ID NO:1所示,其中1-324为VP0氨基酸序列(SEQ ID NO:3),325-564为VP3氨基酸序列(SEQ ID NO:4),565-862为VP1氨基酸序列(SEQ ID NO:5)。优化后的核苷酸序列如SEQ ID NO:2所示。VP0的核苷酸序列如SEQ IDNO:8所示,即SEQ ID NO:2中的1-972。VP3的核苷酸序列如SEQ ID NO:9所示,即SEQ ID NO:2中的973-1692。VP1的核苷酸序列如SEQ ID NO:10所示,即SEQ ID NO:2中的1693-2586。VP1-N50的核苷酸序列如SEQ ID NO:11所示。VP1-N72的核苷酸序列如SEQ ID NO:12所示。VP1-N50的氨基酸序列如SEQ ID NO:6所示。VP1-N72的氨基酸序列如SEQ ID NO:7所示。
表达质粒的制备:根据优化后VP0、VP1、VP3的核苷酸序列及表达载体pPink-HC(购自Invitrogen)多克隆位点处序列设计合成重组引物(表1,其中HS10VP1-N50-R和HS10VP1-N72-R与HS10VP1-R序列相同,表1中未重复列出),使用同源重组试剂盒(购自诺唯赞)将VP0、VP3、VP1、VP1-N50和VP1-N72通过重组的方式分别连接到载体pPinK-HC中分别得到中间质粒pPink/HC-A10 VP0、pPink/HC-A10 VP3、pPink/HC-A10 VP1、pPink/HC-A10 VP1-N50和pPink/HC-A10 VP1-N72;利用同尾酶BglⅡ和BamHⅠ以酶切连接的方法依次将中间质粒中A10VP3表达框和A10 VP0表达框连入pPink/HC-A10 VP1、pPink/HC-A10 VP1-N50或pPink/HC-A10 VP1-N72中,分别得到终质粒pPink/HC-A10 VPN-full(核苷酸序列如SEQ ID NO:13所示)、pPink/HC-A10 VPN-N50(核苷酸序列如SEQ ID NO:14所示)和pPink/HC-A10 VPN-N72(核苷酸序列如SEQ ID NO:15所示),示意图如图1所示。
表1同源重组引物序列
引物名称 | 序列号 | 引物序列 |
HS10 VP0-F | SEQ ID NO:16 | 5’-caactaattattcgaaacggaattcaccatgggtgctcaagtttctac-3’ |
HS10VP0-R | SEQ ID NO:17 | 5’-ctgtatttaaatggccggccggtacctcattattgagaaacagcttgtctc-3’ |
HS10VP3-F | SEQ ID NO:18 | 5’-caactaattattcgaaacggaattcaccatgggtattccagctgagttg-3’ |
HS10VP3-R | SEQ ID NO:19 | 5’-ctgtatttaaatggccggccggtacctcattattgcaaaacagcttgttgag-3’ |
HS10VP1-F | SEQ ID NO:20 | 5’-caactaattattcgaaacggaattcaccatgggcgaccgggtggccg-3’ |
HS10VP1-R | SEQ ID NO:21 | 5’-ctgtatttaaatggccggccggtacctcattacagtgtggtgatggcggtc-3’ |
HS10VP1-N50-F | SEQ ID NO:22 | 5’-acaactaattattcgaaacggaattcaccatggagacgggggccacgtcc-3’ |
HS10VP1-N72-F | SEQ ID NO:23 | 5’-acaactaattattcgaaacggaattcaccatgaacggggttttggaaacg-3’ |
实施例2柯萨奇病毒A10高表达菌株的筛选、表达与纯化
高表达菌株的筛选
将实施例1制备的三个终质粒pPink/HC-A10 VPN-full、pPink/HC-A10 VPN-N50或pPink/HC-A10 VPN-N72分别使用内切酶AflⅡ进行线性化,并用乙醇沉淀法进行纯化回收;利用电转的方法将线性化质粒分别导入不同的毕赤酵母中进行基因重组,涂布PAD平板与30℃进行培养;3天后,挑取大的白色菌落与24孔深孔板中进行甲醇诱导表达,诱导表达48h后收取诱导菌体使用营养筛选法和夹心ELISA的方法进行表达检测,表达量高的作为高表达株A10 VLP-full、A10 VLP-N50和A10 VLP-N72,各高表达菌株目的基因序列经测序分析与理论核苷酸序列一致。
夹心ELISA方法所用的兔抗柯萨奇病毒A10多抗血清和柯萨奇病毒A10特异的鼠单抗均为本公司自制,制备步骤如下:(1)兔抗柯萨奇病毒A10多抗血清:将纯化后的柯萨奇病毒A10 VLP(500μg/只)与弗氏佐剂1:1混合乳化后皮下多点注射成年的新西兰大白兔(1ml/只),两次免疫间隔4周共免疫4次,第4次免疫2周后采取兔血清备用;(2)柯萨奇病毒A10特异的鼠单抗:将纯化后的柯萨奇病毒A10 VLP(5μg/只)与铝佐剂(500μg/只)充分混合后,腹腔注射小鼠,两次免疫间隔2周共免疫4次,第4次免疫后2周取脾脏细胞与骨髓瘤细胞融合后筛选得到柯萨奇病毒A10特异的鼠单抗细胞株,将该细胞株腹腔注射小鼠后获得腹水,经protein G填料纯化后获得A10特异的鼠单抗备用。
夹心ELISA方法操作步骤如下:将兔抗柯萨奇病毒A10多抗血清按1:2000进行稀释包被于96孔酶标板中,50μl/孔,4℃包被过夜后用5%脱脂奶粉进行封闭;将菌体用PBS重悬,加入等体积玻璃珠后70HZ破碎120s,离心后取上清备用;破菌上清和柯萨奇病毒A10VLP自制标品用2%脱脂奶粉进行适当的稀释后加到封闭后的酶标板中,于37℃进行孵育;2h后,加入柯萨奇病毒A10特异的鼠单抗,于37℃进行孵育;2h后,加入1:5000稀释的HRP标记的山羊抗鼠二抗,37℃孵育1h后进行显色并读取450nm吸光值,并根据标曲计算VLP含量。
表达与纯化
将筛选得到的高表达株A10 VLP-full、A10 VLP-N50和A10 VLP-N72分别接种于BMGY培养基,培养24h后更换为BMMY培养基进行诱导表达,诱导48h离心收获菌体。将菌体用PBS重悬后使用高压匀浆机1200bar进行破菌,离心后收集上清进行PEG沉降,复溶后的上清使用DEAE填料进行纯化,最终获得目的VLPs,分别命名为A10 VLP-full、A10 VLP-N50和A10 VLP-N72。
实施例3柯萨奇病毒A10 VLP聚丙烯酰胺凝胶电泳
将纯化后的样品与上样缓冲液混合,100℃加热5-10min后上样到12%SDS-聚丙烯酰胺凝胶上进行电泳,电泳结束后进行考马斯亮蓝染色。蔗糖梯度样品SDS-PAGE结果显示各VLP均由VP0、VP1和VP3组成,A10 VLP-full(图2A)的VP1出现降解,而A10 VLP-N50(图2B)和A10 VLP-N72(图2C)无明显降解。此外,由于是串联表达VP0、VP3和VP1衣壳蛋白,故A10 VLP-full、A10 VLP-N50和A10 VLP-N72不存在切割不完全的问题,也不存在3CD残留问题。
实施例4柯萨奇病毒A10 VLP的粒径研究
将纯化后的柯萨奇病毒A10 VLP用PBS稀释至50-200ng/μl,取1ml加入样品池中,避免产生气泡,将样品池放入Zetasizer设备中采用动态光散射的方法测定其水合直径并进行数据分析。结果如图3所示,A10 VLP-full、A10 VLP-N50和A10 VLP-N72的水合直径相似均为40nm左右,故A10 VLP-full、A10 VLP-N50和A10 VLP-N72均组装良好。
实施例5柯萨奇病毒A10 VLP的免疫原性
为了确定VP1 N端的截短是否影响柯萨奇病毒A10 VLP的免疫原性,我们将A10VLP-full、A10 VLP-N50和A10 VLP-N72分别免疫小鼠,具体步骤如下:6-8周龄雌性ICR小鼠,共分为2组,每组5-6只。将VLP-full(10μg/只)、VLP-N50(10μg/只)或VLP-N72(10μg/只)与铝佐剂(80μg/只)室温振荡吸附1-2h,然后进行腹腔注射,共免疫3次,每两次免疫之间间隔2周。分别于第二次免疫后和第三次免疫后2周采取小鼠血清测定特异抗体滴度。柯萨奇病毒A10VLP特异抗体滴度测定
将兔抗柯萨奇病毒A10 VLP包被于96孔酶标板中,20ng/孔,4℃包被过夜后用5%脱脂奶粉进行封闭;将血清样品用2%脱脂奶粉进行倍比稀释后加到封闭后的酶标板中,于37℃进行孵育;2h后,加入1:5000稀释的HRP标记的山羊抗鼠二抗,37℃孵育1h后进行显色并读取450nm吸光值。如图4A-B所示,不论免疫2次(图4A)还是3次(图4B)VLP-N50和VLP-N72均可诱导与VLP-full相当水平的特异性抗体。
使用GraphPad Prism 8.3.0进行数据处理,使用t检验进行差异分析,P<0.05,*,P<0.01,**,P<0.001,***。
本发明将含柯萨奇病毒A10 VP0、VP1与VP3串联表达框的表达载体导入毕赤酵母,以达到同时表达柯萨奇病毒A10 VP0、VP1与VP3衣壳蛋白的目的,经检测发现VP0、VP1与VP3衣壳蛋白可成功表达且可自发组装VLP。VLP-full不存在P1切割不完全的问题,可在小鼠体内诱导较高特异抗体反应,但VLP-full仍存在VP1不同程度降解的问题。为解决该问题,本发明在衣壳蛋白串联表达的基础上对VP1 N端进行不同程度的截短,SDS-PAGE结果显示VLP-N50和VLP-N72的VP1均无明显的降解;此外,VLP-N50和VLP-N72,亦可诱导良好的免疫反应,且抗体水平与VLP-full相当。
综上,VLP-N50和VLP-N72组成均一且免疫原性良好,可用于柯萨奇病毒A10进一步的疫苗研发。
以上的实施例是为了说明本发明公开的实施方案,并不能理解为对本发明的限制。此外,本文所列出的各种修改以及发明中方法的变化,在不脱离本发明的范围和精神的前提下对本领域内的技术人员来说是显而易见的。虽然已结合本发明的多种具体优选实施例对本发明进行了具体的描述,但应当理解,本发明不应仅限于这些具体实施例。事实上,各种如上所述的对本领域内的技术人员来说显而易见的修改来获取发明都应包括在本发明的范围内。
序列表
<110> 华淞(上海)生物医药科技有限公司
<120> 重组柯萨奇病毒A10病毒样颗粒及其用途
<160> 23
<170> SIPOSequenceListing 1.0
<210> 1
<211> 862
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 1
Met Gly Ala Gln Val Ser Thr Gln Lys Ser Gly Ser His Glu Thr Gly
1 5 10 15
Asn Val Ala Thr Gly Gly Ser Thr Ile Asn Phe Thr Asn Ile Asn Tyr
20 25 30
Tyr Lys Asp Ser Tyr Ala Ala Ser Ala Thr Arg Gln Asp Phe Thr Gln
35 40 45
Asp Pro Lys Lys Phe Thr Gln Pro Val Leu Asp Ser Ile Arg Glu Leu
50 55 60
Ser Ala Pro Leu Asn Ser Pro Ser Val Glu Ala Cys Gly Tyr Ser Asp
65 70 75 80
Arg Val Ala Gln Leu Thr Val Gly Asn Ser Ser Ile Thr Thr Gln Glu
85 90 95
Ala Ala Asn Ile Val Leu Ala Tyr Gly Glu Trp Pro Glu Tyr Cys Pro
100 105 110
Asp Thr Asp Ala Thr Ala Val Asp Lys Pro Thr Arg Pro Asp Val Ser
115 120 125
Val Asn Arg Phe Tyr Thr Leu Asp Ser Lys Met Trp Gln Glu Asn Ser
130 135 140
Thr Gly Trp Tyr Trp Lys Phe Pro Asp Val Leu Asn Lys Thr Gly Val
145 150 155 160
Phe Gly Gln Asn Ala Gln Phe His Tyr Leu Tyr Arg Ser Gly Phe Cys
165 170 175
Leu His Val Gln Cys Asn Ala Ser Lys Phe His Gln Gly Ala Leu Leu
180 185 190
Val Ala Val Ile Pro Glu Phe Val Ile Ala Gly Arg Gly Ser Asn Thr
195 200 205
Lys Pro Asn Glu Ala Pro His Pro Gly Phe Thr Thr Thr Phe Pro Gly
210 215 220
Thr Thr Gly Ala Thr Phe His Asp Pro Tyr Val Leu Asp Ser Gly Val
225 230 235 240
Pro Leu Ser Gln Ala Leu Ile Tyr Pro His Gln Trp Ile Asn Leu Arg
245 250 255
Thr Asn Asn Cys Ala Thr Val Ile Val Pro Tyr Ile Asn Ala Val Pro
260 265 270
Phe Asp Ser Ala Ile Asn His Ser Asn Phe Gly Leu Ile Val Ile Pro
275 280 285
Val Ser Pro Leu Lys Tyr Ser Ser Gly Ala Thr Thr Ala Ile Pro Ile
290 295 300
Thr Ile Thr Ile Ala Pro Leu Asn Ser Glu Phe Gly Gly Leu Arg Gln
305 310 315 320
Ala Val Ser Gln Gly Ile Pro Ala Glu Leu Arg Pro Gly Thr Asn Gln
325 330 335
Phe Leu Thr Thr Asp Asp Asp Thr Ala Ala Pro Ile Leu Pro Gly Phe
340 345 350
Thr Pro Thr Pro Thr Ile His Ile Pro Gly Glu Val His Ser Leu Leu
355 360 365
Glu Leu Cys Arg Val Glu Thr Ile Leu Glu Val Asn Asn Thr Thr Glu
370 375 380
Ala Thr Gly Leu Thr Arg Leu Leu Ile Pro Val Ser Ser Gln Asn Lys
385 390 395 400
Ala Asp Glu Leu Cys Ala Ala Phe Met Val Asp Pro Gly Arg Ile Gly
405 410 415
Pro Trp Gln Ser Thr Leu Val Gly Gln Ile Cys Arg Tyr Tyr Thr Gln
420 425 430
Trp Ser Gly Ser Leu Lys Val Thr Phe Met Phe Thr Gly Ser Phe Met
435 440 445
Ala Thr Gly Lys Met Leu Val Ala Tyr Ser Pro Pro Gly Ser Ala Gln
450 455 460
Pro Ala Asn Arg Glu Thr Ala Met Leu Gly Thr His Val Ile Trp Asp
465 470 475 480
Phe Gly Leu Gln Ser Ser Val Ser Leu Val Ile Pro Trp Ile Ser Asn
485 490 495
Thr His Phe Arg Thr Ala Lys Thr Gly Gly Asn Tyr Asp Tyr Tyr Thr
500 505 510
Ala Gly Val Val Thr Leu Trp Tyr Gln Thr Asn Tyr Val Val Pro Pro
515 520 525
Glu Thr Pro Gly Glu Ala Tyr Ile Ile Ala Met Gly Ala Ala Gln Asp
530 535 540
Asn Phe Thr Leu Lys Ile Cys Lys Asp Thr Asp Glu Val Thr Gln Gln
545 550 555 560
Ala Val Leu Gln Gly Asp Pro Val Glu Asp Ile Ile His Asp Ala Leu
565 570 575
Gly Asn Thr Ala Arg Arg Ala Ile Ser Ser Val Thr Asn Val Glu Ser
580 585 590
Ala Ala Asn Thr Thr Pro Ser Ser His Arg Leu Glu Thr Gly Arg Val
595 600 605
Pro Ala Leu Gln Ala Ala Glu Thr Gly Ala Thr Ser Asn Ala Thr Asp
610 615 620
Glu Asn Met Ile Glu Thr Arg Cys Val Val Asn Arg Asn Gly Val Leu
625 630 635 640
Glu Thr Thr Ile Asn His Phe Phe Ser Arg Ser Gly Leu Val Gly Val
645 650 655
Val Asn Leu Thr Asp Gly Gly Thr Asp Thr Thr Gly Tyr Ala Thr Trp
660 665 670
Asp Ile Asp Ile Met Gly Phe Val Gln Leu Arg Arg Lys Cys Glu Met
675 680 685
Phe Thr Tyr Met Arg Phe Asn Ala Glu Phe Thr Phe Val Thr Thr Thr
690 695 700
Lys Asn Gly Glu Ala Arg Pro Tyr Met Leu Gln Tyr Met Tyr Val Pro
705 710 715 720
Pro Gly Ala Pro Lys Pro Thr Gly Arg Asp Ala Phe Gln Trp Gln Thr
725 730 735
Ala Thr Asn Pro Ser Val Phe Val Lys Leu Thr Asp Pro Pro Ala Gln
740 745 750
Val Ser Val Pro Phe Met Ser Pro Ala Ser Ala Tyr Gln Trp Phe Tyr
755 760 765
Asp Gly Tyr Pro Thr Phe Gly Gln His Pro Glu Thr Ser Asn Thr Thr
770 775 780
Tyr Gly Leu Cys Pro Asn Asn Met Met Gly Thr Phe Ala Val Arg Val
785 790 795 800
Val Ser Arg Glu Ala Ser Gln Leu Lys Leu Gln Thr Arg Val Tyr Met
805 810 815
Lys Leu Lys His Val Arg Ala Trp Val Pro Arg Pro Ile Arg Ser Gln
820 825 830
Pro Tyr Leu Leu Lys Asn Phe Pro Asn Tyr Asp Ser Ser Lys Val Thr
835 840 845
Asn Ser Ala Arg Asp Arg Ser Ser Ile Lys Gln Ala Asn Met
850 855 860
<210> 2
<211> 2586
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 2
atgggcgctc aggtaagcac tcagaaatcc ggttcacacg aaaccggaaa cgtagccacc 60
ggtgggtcta cgatcaattt tacaaatata aattattata aggattctta cgcagcctcc 120
gcaaccagac aagactttac ccaggacccc aaaaaattca cccaaccagt attggattcg 180
attagagaac tcagcgcgcc cttaaatagt ccttcagttg aggcatgcgg atacagcgat 240
agagtggcgc aactaacagt cggcaacagc tccatcacga ctcaggaggc agccaacatc 300
gtcctcgctt atggggagtg gcccgagtac tgtcctgata ctgacgccac agcagtcgat 360
aagcctacac ggcctgatgt gtcggttaat cgcttctaca ctcttgatag taagatgtgg 420
caggagaact ctacaggttg gtattggaaa ttcccggacg tcttaaataa gactggcgtg 480
ttcgggcaga atgctcagtt ccactacctg taccgctcag ggttttgcct tcatgttcaa 540
tgtaacgcca gtaagtttca tcagggcgcc ttactagtag cggtgatccc cgaatttgtg 600
attgcggggc gaggttcaaa tacgaaaccg aatgaggcgc cacatcccgg attcacaaca 660
accttcccag ggactactgg agctactttt catgacccat acgtgctaga ctccggggtg 720
ccactctctc aggccctaat ttatcctcat caatggatta atttgcgaac gaataactgc 780
gctacagtga tcgtcccgta cattaatgct gttccttttg atagcgctat caaccactct 840
aacttcggcc tcatcgttat cccggtgagt cctctgaagt atagttcagg tgcgacgacc 900
gcaattccaa taactattac gatagctccg ttaaatagcg agttcggtgg tctgcgacag 960
gcagtctcgc agggcatacc agcagagctg aggccgggaa ccaaccaatt tctcacaacg 1020
gacgatgata cagcggcccc catccttcca ggcttcacac ctacccccac catacatatc 1080
ccgggcgaag tccactctct cttggaactt tgccgtgtcg aaactatctt ggaggtgaac 1140
aacacgactg aagcaacagg actcacgcgt cttttaatac ctgtctcttc gcaaaacaag 1200
gcggacgagt tatgcgcggc ctttatggtc gatccgggac ggattggccc atggcaatca 1260
actctagtag gtcagatatg taggtactat acccagtggt ctggttcgtt aaaagttact 1320
tttatgttta ctgggagttt catggccaca ggtaagatgc tggttgccta ctcaccaccg 1380
gggtctgccc agcccgcgaa cagagaaacg gcaatgctag gtacacacgt catatgggat 1440
tttggccttc agagttcagt atccctggtg attccttgga ttagcaatac acactttcgc 1500
acagccaaga cgggaggaaa ctacgactac tataccgcgg gtgtagttac cttatggtat 1560
caaacgaact atgttgttcc acccgaaaca cccggcgaag cttacatcat agccatggga 1620
gcagcacagg acaattttac cctgaaaatt tgtaaggata ctgacgaggt gacccaacaa 1680
gctgttctgc aaggggaccc tgttgaggat ataattcacg atgcgttggg taacacggcg 1740
cgcagggcta tatcatcggt taccaatgtc gaaagtgccg caaatacaac accatcgtcg 1800
catcgtctcg agactgggag agtccctgca ctacaagccg ccgagacggg ggccacgtcc 1860
aacgcaacgg acgaaaatat gatagaaacg aggtgtgtcg tgaatcggaa cggggttttg 1920
gaaacgacta ttaaccactt cttcagcagg agtggactag taggggtcgt caaccttact 1980
gacggaggca ccgacaccac tggctatgct acctgggata tcgacattat gggtttcgta 2040
caactacgtc gtaaatgcga gatgtttaca tatatgaggt tcaacgctga gtttacattt 2100
gtcaccacga caaaaaacgg cgaggcccga ccgtatatgc ttcagtacat gtatgtgccc 2160
cccggtgctc caaaaccaac tggaagagac gcattccaat ggcaaactgc aacgaatccg 2220
tccgtgtttg taaagctcac tgatccgcct gctcaagttt ccgtaccgtt catgtcaccc 2280
gcttccgcct atcaatggtt ctatgatgga tatcccacct tcggacaaca ccctgaaacg 2340
tccaatacta cttatggctt atgtccgaat aatatgatgg gtacgttcgc tgtacgggta 2400
gtttcacgag aagcaagcca gttaaaactt caaacacggg tatacatgaa gttgaaacat 2460
gtgcgggcgt gggtgcctcg ccctatacgt agccagccat acctgctcaa aaattttccg 2520
aattatgact cttcgaaggt tacgaactca gctcgcgacc gatcgtcgat caaacaagcg 2580
aacatg 2586
<210> 3
<211> 324
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 3
Met Gly Ala Gln Val Ser Thr Gln Lys Ser Gly Ser His Glu Thr Gly
1 5 10 15
Asn Val Ala Thr Gly Gly Ser Thr Ile Asn Phe Thr Asn Ile Asn Tyr
20 25 30
Tyr Lys Asp Ser Tyr Ala Ala Ser Ala Thr Arg Gln Asp Phe Thr Gln
35 40 45
Asp Pro Lys Lys Phe Thr Gln Pro Val Leu Asp Ser Ile Arg Glu Leu
50 55 60
Ser Ala Pro Leu Asn Ser Pro Ser Val Glu Ala Cys Gly Tyr Ser Asp
65 70 75 80
Arg Val Ala Gln Leu Thr Val Gly Asn Ser Ser Ile Thr Thr Gln Glu
85 90 95
Ala Ala Asn Ile Val Leu Ala Tyr Gly Glu Trp Pro Glu Tyr Cys Pro
100 105 110
Asp Thr Asp Ala Thr Ala Val Asp Lys Pro Thr Arg Pro Asp Val Ser
115 120 125
Val Asn Arg Phe Tyr Thr Leu Asp Ser Lys Met Trp Gln Glu Asn Ser
130 135 140
Thr Gly Trp Tyr Trp Lys Phe Pro Asp Val Leu Asn Lys Thr Gly Val
145 150 155 160
Phe Gly Gln Asn Ala Gln Phe His Tyr Leu Tyr Arg Ser Gly Phe Cys
165 170 175
Leu His Val Gln Cys Asn Ala Ser Lys Phe His Gln Gly Ala Leu Leu
180 185 190
Val Ala Val Ile Pro Glu Phe Val Ile Ala Gly Arg Gly Ser Asn Thr
195 200 205
Lys Pro Asn Glu Ala Pro His Pro Gly Phe Thr Thr Thr Phe Pro Gly
210 215 220
Thr Thr Gly Ala Thr Phe His Asp Pro Tyr Val Leu Asp Ser Gly Val
225 230 235 240
Pro Leu Ser Gln Ala Leu Ile Tyr Pro His Gln Trp Ile Asn Leu Arg
245 250 255
Thr Asn Asn Cys Ala Thr Val Ile Val Pro Tyr Ile Asn Ala Val Pro
260 265 270
Phe Asp Ser Ala Ile Asn His Ser Asn Phe Gly Leu Ile Val Ile Pro
275 280 285
Val Ser Pro Leu Lys Tyr Ser Ser Gly Ala Thr Thr Ala Ile Pro Ile
290 295 300
Thr Ile Thr Ile Ala Pro Leu Asn Ser Glu Phe Gly Gly Leu Arg Gln
305 310 315 320
Ala Val Ser Gln
<210> 4
<211> 241
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 4
Met Gly Ile Pro Ala Glu Leu Arg Pro Gly Thr Asn Gln Phe Leu Thr
1 5 10 15
Thr Asp Asp Asp Thr Ala Ala Pro Ile Leu Pro Gly Phe Thr Pro Thr
20 25 30
Pro Thr Ile His Ile Pro Gly Glu Val His Ser Leu Leu Glu Leu Cys
35 40 45
Arg Val Glu Thr Ile Leu Glu Val Asn Asn Thr Thr Glu Ala Thr Gly
50 55 60
Leu Thr Arg Leu Leu Ile Pro Val Ser Ser Gln Asn Lys Ala Asp Glu
65 70 75 80
Leu Cys Ala Ala Phe Met Val Asp Pro Gly Arg Ile Gly Pro Trp Gln
85 90 95
Ser Thr Leu Val Gly Gln Ile Cys Arg Tyr Tyr Thr Gln Trp Ser Gly
100 105 110
Ser Leu Lys Val Thr Phe Met Phe Thr Gly Ser Phe Met Ala Thr Gly
115 120 125
Lys Met Leu Val Ala Tyr Ser Pro Pro Gly Ser Ala Gln Pro Ala Asn
130 135 140
Arg Glu Thr Ala Met Leu Gly Thr His Val Ile Trp Asp Phe Gly Leu
145 150 155 160
Gln Ser Ser Val Ser Leu Val Ile Pro Trp Ile Ser Asn Thr His Phe
165 170 175
Arg Thr Ala Lys Thr Gly Gly Asn Tyr Asp Tyr Tyr Thr Ala Gly Val
180 185 190
Val Thr Leu Trp Tyr Gln Thr Asn Tyr Val Val Pro Pro Glu Thr Pro
195 200 205
Gly Glu Ala Tyr Ile Ile Ala Met Gly Ala Ala Gln Asp Asn Phe Thr
210 215 220
Leu Lys Ile Cys Lys Asp Thr Asp Glu Val Thr Gln Gln Ala Val Leu
225 230 235 240
Gln
<210> 5
<211> 299
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 5
Met Gly Asp Pro Val Glu Asp Ile Ile His Asp Ala Leu Gly Asn Thr
1 5 10 15
Ala Arg Arg Ala Ile Ser Ser Val Thr Asn Val Glu Ser Ala Ala Asn
20 25 30
Thr Thr Pro Ser Ser His Arg Leu Glu Thr Gly Arg Val Pro Ala Leu
35 40 45
Gln Ala Ala Glu Thr Gly Ala Thr Ser Asn Ala Thr Asp Glu Asn Met
50 55 60
Ile Glu Thr Arg Cys Val Val Asn Arg Asn Gly Val Leu Glu Thr Thr
65 70 75 80
Ile Asn His Phe Phe Ser Arg Ser Gly Leu Val Gly Val Val Asn Leu
85 90 95
Thr Asp Gly Gly Thr Asp Thr Thr Gly Tyr Ala Thr Trp Asp Ile Asp
100 105 110
Ile Met Gly Phe Val Gln Leu Arg Arg Lys Cys Glu Met Phe Thr Tyr
115 120 125
Met Arg Phe Asn Ala Glu Phe Thr Phe Val Thr Thr Thr Lys Asn Gly
130 135 140
Glu Ala Arg Pro Tyr Met Leu Gln Tyr Met Tyr Val Pro Pro Gly Ala
145 150 155 160
Pro Lys Pro Thr Gly Arg Asp Ala Phe Gln Trp Gln Thr Ala Thr Asn
165 170 175
Pro Ser Val Phe Val Lys Leu Thr Asp Pro Pro Ala Gln Val Ser Val
180 185 190
Pro Phe Met Ser Pro Ala Ser Ala Tyr Gln Trp Phe Tyr Asp Gly Tyr
195 200 205
Pro Thr Phe Gly Gln His Pro Glu Thr Ser Asn Thr Thr Tyr Gly Leu
210 215 220
Cys Pro Asn Asn Met Met Gly Thr Phe Ala Val Arg Val Val Ser Arg
225 230 235 240
Glu Ala Ser Gln Leu Lys Leu Gln Thr Arg Val Tyr Met Lys Leu Lys
245 250 255
His Val Arg Ala Trp Val Pro Arg Pro Ile Arg Ser Gln Pro Tyr Leu
260 265 270
Leu Lys Asn Phe Pro Asn Tyr Asp Ser Ser Lys Val Thr Asn Ser Ala
275 280 285
Arg Asp Arg Ser Ser Ile Lys Gln Ala Asn Met
290 295
<210> 6
<211> 249
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 6
Met Glu Thr Gly Ala Thr Ser Asn Ala Thr Asp Glu Asn Met Ile Glu
1 5 10 15
Thr Arg Cys Val Val Asn Arg Asn Gly Val Leu Glu Thr Thr Ile Asn
20 25 30
His Phe Phe Ser Arg Ser Gly Leu Val Gly Val Val Asn Leu Thr Asp
35 40 45
Gly Gly Thr Asp Thr Thr Gly Tyr Ala Thr Trp Asp Ile Asp Ile Met
50 55 60
Gly Phe Val Gln Leu Arg Arg Lys Cys Glu Met Phe Thr Tyr Met Arg
65 70 75 80
Phe Asn Ala Glu Phe Thr Phe Val Thr Thr Thr Lys Asn Gly Glu Ala
85 90 95
Arg Pro Tyr Met Leu Gln Tyr Met Tyr Val Pro Pro Gly Ala Pro Lys
100 105 110
Pro Thr Gly Arg Asp Ala Phe Gln Trp Gln Thr Ala Thr Asn Pro Ser
115 120 125
Val Phe Val Lys Leu Thr Asp Pro Pro Ala Gln Val Ser Val Pro Phe
130 135 140
Met Ser Pro Ala Ser Ala Tyr Gln Trp Phe Tyr Asp Gly Tyr Pro Thr
145 150 155 160
Phe Gly Gln His Pro Glu Thr Ser Asn Thr Thr Tyr Gly Leu Cys Pro
165 170 175
Asn Asn Met Met Gly Thr Phe Ala Val Arg Val Val Ser Arg Glu Ala
180 185 190
Ser Gln Leu Lys Leu Gln Thr Arg Val Tyr Met Lys Leu Lys His Val
195 200 205
Arg Ala Trp Val Pro Arg Pro Ile Arg Ser Gln Pro Tyr Leu Leu Lys
210 215 220
Asn Phe Pro Asn Tyr Asp Ser Ser Lys Val Thr Asn Ser Ala Arg Asp
225 230 235 240
Arg Ser Ser Ile Lys Gln Ala Asn Met
245
<210> 7
<211> 227
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 7
Met Asn Gly Val Leu Glu Thr Thr Ile Asn His Phe Phe Ser Arg Ser
1 5 10 15
Gly Leu Val Gly Val Val Asn Leu Thr Asp Gly Gly Thr Asp Thr Thr
20 25 30
Gly Tyr Ala Thr Trp Asp Ile Asp Ile Met Gly Phe Val Gln Leu Arg
35 40 45
Arg Lys Cys Glu Met Phe Thr Tyr Met Arg Phe Asn Ala Glu Phe Thr
50 55 60
Phe Val Thr Thr Thr Lys Asn Gly Glu Ala Arg Pro Tyr Met Leu Gln
65 70 75 80
Tyr Met Tyr Val Pro Pro Gly Ala Pro Lys Pro Thr Gly Arg Asp Ala
85 90 95
Phe Gln Trp Gln Thr Ala Thr Asn Pro Ser Val Phe Val Lys Leu Thr
100 105 110
Asp Pro Pro Ala Gln Val Ser Val Pro Phe Met Ser Pro Ala Ser Ala
115 120 125
Tyr Gln Trp Phe Tyr Asp Gly Tyr Pro Thr Phe Gly Gln His Pro Glu
130 135 140
Thr Ser Asn Thr Thr Tyr Gly Leu Cys Pro Asn Asn Met Met Gly Thr
145 150 155 160
Phe Ala Val Arg Val Val Ser Arg Glu Ala Ser Gln Leu Lys Leu Gln
165 170 175
Thr Arg Val Tyr Met Lys Leu Lys His Val Arg Ala Trp Val Pro Arg
180 185 190
Pro Ile Arg Ser Gln Pro Tyr Leu Leu Lys Asn Phe Pro Asn Tyr Asp
195 200 205
Ser Ser Lys Val Thr Asn Ser Ala Arg Asp Arg Ser Ser Ile Lys Gln
210 215 220
Ala Asn Met
225
<210> 8
<211> 972
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 8
atgggcgctc aggtaagcac tcagaaatcc ggttcacacg aaaccggaaa cgtagccacc 60
ggtgggtcta cgatcaattt tacaaatata aattattata aggattctta cgcagcctcc 120
gcaaccagac aagactttac ccaggacccc aaaaaattca cccaaccagt attggattcg 180
attagagaac tcagcgcgcc cttaaatagt ccttcagttg aggcatgcgg atacagcgat 240
agagtggcgc aactaacagt cggcaacagc tccatcacga ctcaggaggc agccaacatc 300
gtcctcgctt atggggagtg gcccgagtac tgtcctgata ctgacgccac agcagtcgat 360
aagcctacac ggcctgatgt gtcggttaat cgcttctaca ctcttgatag taagatgtgg 420
caggagaact ctacaggttg gtattggaaa ttcccggacg tcttaaataa gactggcgtg 480
ttcgggcaga atgctcagtt ccactacctg taccgctcag ggttttgcct tcatgttcaa 540
tgtaacgcca gtaagtttca tcagggcgcc ttactagtag cggtgatccc cgaatttgtg 600
attgcggggc gaggttcaaa tacgaaaccg aatgaggcgc cacatcccgg attcacaaca 660
accttcccag ggactactgg agctactttt catgacccat acgtgctaga ctccggggtg 720
ccactctctc aggccctaat ttatcctcat caatggatta atttgcgaac gaataactgc 780
gctacagtga tcgtcccgta cattaatgct gttccttttg atagcgctat caaccactct 840
aacttcggcc tcatcgttat cccggtgagt cctctgaagt atagttcagg tgcgacgacc 900
gcaattccaa taactattac gatagctccg ttaaatagcg agttcggtgg tctgcgacag 960
gcagtctcgc ag 972
<210> 9
<211> 723
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 9
atgggcatac cagcagagct gaggccggga accaaccaat ttctcacaac ggacgatgat 60
acagcggccc ccatccttcc aggcttcaca cctaccccca ccatacatat cccgggcgaa 120
gtccactctc tcttggaact ttgccgtgtc gaaactatct tggaggtgaa caacacgact 180
gaagcaacag gactcacgcg tcttttaata cctgtctctt cgcaaaacaa ggcggacgag 240
ttatgcgcgg cctttatggt cgatccggga cggattggcc catggcaatc aactctagta 300
ggtcagatat gtaggtacta tacccagtgg tctggttcgt taaaagttac ttttatgttt 360
actgggagtt tcatggccac aggtaagatg ctggttgcct actcaccacc ggggtctgcc 420
cagcccgcga acagagaaac ggcaatgcta ggtacacacg tcatatggga ttttggcctt 480
cagagttcag tatccctggt gattccttgg attagcaata cacactttcg cacagccaag 540
acgggaggaa actacgacta ctataccgcg ggtgtagtta ccttatggta tcaaacgaac 600
tatgttgttc cacccgaaac acccggcgaa gcttacatca tagccatggg agcagcacag 660
gacaatttta ccctgaaaat ttgtaaggat actgacgagg tgacccaaca agctgttctg 720
caa 723
<210> 10
<211> 897
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 10
atgggggacc ctgttgagga tataattcac gatgcgttgg gtaacacggc gcgcagggct 60
atatcatcgg ttaccaatgt cgaaagtgcc gcaaatacaa caccatcgtc gcatcgtctc 120
gagactggga gagtccctgc actacaagcc gccgagacgg gggccacgtc caacgcaacg 180
gacgaaaata tgatagaaac gaggtgtgtc gtgaatcgga acggggtttt ggaaacgact 240
attaaccact tcttcagcag gagtggacta gtaggggtcg tcaaccttac tgacggaggc 300
accgacacca ctggctatgc tacctgggat atcgacatta tgggtttcgt acaactacgt 360
cgtaaatgcg agatgtttac atatatgagg ttcaacgctg agtttacatt tgtcaccacg 420
acaaaaaacg gcgaggcccg accgtatatg cttcagtaca tgtatgtgcc ccccggtgct 480
ccaaaaccaa ctggaagaga cgcattccaa tggcaaactg caacgaatcc gtccgtgttt 540
gtaaagctca ctgatccgcc tgctcaagtt tccgtaccgt tcatgtcacc cgcttccgcc 600
tatcaatggt tctatgatgg atatcccacc ttcggacaac accctgaaac gtccaatact 660
acttatggct tatgtccgaa taatatgatg ggtacgttcg ctgtacgggt agtttcacga 720
gaagcaagcc agttaaaact tcaaacacgg gtatacatga agttgaaaca tgtgcgggcg 780
tgggtgcctc gccctatacg tagccagcca tacctgctca aaaattttcc gaattatgac 840
tcttcgaagg ttacgaactc agctcgcgac cgatcgtcga tcaaacaagc gaacatg 897
<210> 11
<211> 747
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 11
atggagacgg gggccacgtc caacgcaacg gacgaaaata tgatagaaac gaggtgtgtc 60
gtgaatcgga acggggtttt ggaaacgact attaaccact tcttcagcag gagtggacta 120
gtaggggtcg tcaaccttac tgacggaggc accgacacca ctggctatgc tacctgggat 180
atcgacatta tgggtttcgt acaactacgt cgtaaatgcg agatgtttac atatatgagg 240
ttcaacgctg agtttacatt tgtcaccacg acaaaaaacg gcgaggcccg accgtatatg 300
cttcagtaca tgtatgtgcc ccccggtgct ccaaaaccaa ctggaagaga cgcattccaa 360
tggcaaactg caacgaatcc gtccgtgttt gtaaagctca ctgatccgcc tgctcaagtt 420
tccgtaccgt tcatgtcacc cgcttccgcc tatcaatggt tctatgatgg atatcccacc 480
ttcggacaac accctgaaac gtccaatact acttatggct tatgtccgaa taatatgatg 540
ggtacgttcg ctgtacgggt agtttcacga gaagcaagcc agttaaaact tcaaacacgg 600
gtatacatga agttgaaaca tgtgcgggcg tgggtgcctc gccctatacg tagccagcca 660
tacctgctca aaaattttcc gaattatgac tcttcgaagg ttacgaactc agctcgcgac 720
cgatcgtcga tcaaacaagc gaacatg 747
<210> 12
<211> 681
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 12
atgaacgggg ttttggaaac gactattaac cacttcttca gcaggagtgg actagtaggg 60
gtcgtcaacc ttactgacgg aggcaccgac accactggct atgctacctg ggatatcgac 120
attatgggtt tcgtacaact acgtcgtaaa tgcgagatgt ttacatatat gaggttcaac 180
gctgagttta catttgtcac cacgacaaaa aacggcgagg cccgaccgta tatgcttcag 240
tacatgtatg tgccccccgg tgctccaaaa ccaactggaa gagacgcatt ccaatggcaa 300
actgcaacga atccgtccgt gtttgtaaag ctcactgatc cgcctgctca agtttccgta 360
ccgttcatgt cacccgcttc cgcctatcaa tggttctatg atggatatcc caccttcgga 420
caacaccctg aaacgtccaa tactacttat ggcttatgtc cgaataatat gatgggtacg 480
ttcgctgtac gggtagtttc acgagaagca agccagttaa aacttcaaac acgggtatac 540
atgaagttga aacatgtgcg ggcgtgggtg cctcgcccta tacgtagcca gccatacctg 600
ctcaaaaatt ttccgaatta tgactcttcg aaggttacga actcagctcg cgaccgatcg 660
tcgatcaaac aagcgaacat g 681
<210> 13
<211> 12759
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 13
agatctaaca tccaaagacg aaaggttgaa tgaaaccttt ttgccatccg acatccacag 60
gtccattctc acacataagt gccaaacgca acaggagggg atacactagc agcagaccgt 120
tgcaaacgca ggacctccac tcctcttctc ctcaacaccc acttttgcca tcgaaaaacc 180
agcccagtta ttgggcttga ttggagctcg ctcattccaa ttccttctat taggctacta 240
acaccatgac tttattagcc tgtctatcct ggcccccctg gcgaggttca tgtttgttta 300
tttccgaatg caacaagctc cgcattacac ccgaacatca ctccagatga gggctttctg 360
agtgtggggt caaatagttt catgttcccc aaatggccca aaactgacag tttaaacgct 420
gtcttggaac ctaatatgac aaaagcgtga tctcatccaa gatgaactaa gtttggttcg 480
ttgaaatgct aacggccagt tggtcaaaaa gaaacttcca aaagtcggca taccgtttgt 540
cttgtttggt attgattgac gaatgctcaa aaataatctc attaatgctt agcgcagtct 600
ctctatcgct tctgaacccc ggtgcacctg tgccgaaacg caaatgggga aacacccgct 660
ttttggatga ttatgcattg tctccacatt gtatgcttcc aagattctgg tgggaatact 720
gctgatagcc taacgttcat gatcaaaatt taactgttct aacccctact tgacagcaat 780
atataaacag aaggaagctg ccctgtctta aacctttttt tttatcatca ttattagctt 840
actttcataa ttgcgactgg ttccaattga caagcttttg attttaacga cttttaacga 900
caacttgaga agatcaaaaa acaactaatt attcgaaacg gaattcacca tgggcgctca 960
ggtaagcact cagaaatccg gttcacacga aaccggaaac gtagccaccg gtgggtctac 1020
gatcaatttt acaaatataa attattataa ggattcttac gcagcctccg caaccagaca 1080
agactttacc caggacccca aaaaattcac ccaaccagta ttggattcga ttagagaact 1140
cagcgcgccc ttaaatagtc cttcagttga ggcatgcgga tacagcgata gagtggcgca 1200
actaacagtc ggcaacagct ccatcacgac tcaggaggca gccaacatcg tcctcgctta 1260
tggggagtgg cccgagtact gtcctgatac tgacgccaca gcagtcgata agcctacacg 1320
gcctgatgtg tcggttaatc gcttctacac tcttgatagt aagatgtggc aggagaactc 1380
tacaggttgg tattggaaat tcccggacgt cttaaataag actggcgtgt tcgggcagaa 1440
tgctcagttc cactacctgt accgctcagg gttttgcctt catgttcaat gtaacgccag 1500
taagtttcat cagggcgcct tactagtagc ggtgatcccc gaatttgtga ttgcggggcg 1560
aggttcaaat acgaaaccga atgaggcgcc acatcccgga ttcacaacaa ccttcccagg 1620
gactactgga gctacttttc atgacccata cgtgctagac tccggggtgc cactctctca 1680
ggccctaatt tatcctcatc aatggattaa tttgcgaacg aataactgcg ctacagtgat 1740
cgtcccgtac attaatgctg ttccttttga tagcgctatc aaccactcta acttcggcct 1800
catcgttatc ccggtgagtc ctctgaagta tagttcaggt gcgacgaccg caattccaat 1860
aactattacg atagctccgt taaatagcga gttcggtggt ctgcgacagg cagtctcgca 1920
gtaatgaggt accggccggc catttaaata caggcccctt ttcctttgtc gatatcatgt 1980
aattagttat gtcacgctta cattcacgcc ctcctcccac atccgctcta accgaaaagg 2040
aaggagttag acaacctgaa gtctaggtcc ctatttattt tttttaatag ttatgttagt 2100
attaagaacg ttatttatat ttcaaatttt tctttttttt ctgtacaaac gcgtgtacgc 2160
atgtaacatt atactgaaaa ccttgcttga gaaggttttg ggacgctcga aggctttaat 2220
ttgcaagctg gatctaacat ccaaagacga aaggttgaat gaaacctttt tgccatccga 2280
catccacagg tccattctca cacataagtg ccaaacgcaa caggagggga tacactagca 2340
gcagaccgtt gcaaacgcag gacctccact cctcttctcc tcaacaccca cttttgccat 2400
cgaaaaacca gcccagttat tgggcttgat tggagctcgc tcattccaat tccttctatt 2460
aggctactaa caccatgact ttattagcct gtctatcctg gcccccctgg cgaggttcat 2520
gtttgtttat ttccgaatgc aacaagctcc gcattacacc cgaacatcac tccagatgag 2580
ggctttctga gtgtggggtc aaatagtttc atgttcccca aatggcccaa aactgacagt 2640
ttaaacgctg tcttggaacc taatatgaca aaagcgtgat ctcatccaag atgaactaag 2700
tttggttcgt tgaaatgcta acggccagtt ggtcaaaaag aaacttccaa aagtcggcat 2760
accgtttgtc ttgtttggta ttgattgacg aatgctcaaa aataatctca ttaatgctta 2820
gcgcagtctc tctatcgctt ctgaaccccg gtgcacctgt gccgaaacgc aaatggggaa 2880
acacccgctt tttggatgat tatgcattgt ctccacattg tatgcttcca agattctggt 2940
gggaatactg ctgatagcct aacgttcatg atcaaaattt aactgttcta acccctactt 3000
gacagcaata tataaacaga aggaagctgc cctgtcttaa accttttttt ttatcatcat 3060
tattagctta ctttcataat tgcgactggt tccaattgac aagcttttga ttttaacgac 3120
ttttaacgac aacttgagaa gatcaaaaaa caactaatta ttcgaaacgg aattcaccat 3180
gggcatacca gcagagctga ggccgggaac caaccaattt ctcacaacgg acgatgatac 3240
agcggccccc atccttccag gcttcacacc tacccccacc atacatatcc cgggcgaagt 3300
ccactctctc ttggaacttt gccgtgtcga aactatcttg gaggtgaaca acacgactga 3360
agcaacagga ctcacgcgtc ttttaatacc tgtctcttcg caaaacaagg cggacgagtt 3420
atgcgcggcc tttatggtcg atccgggacg gattggccca tggcaatcaa ctctagtagg 3480
tcagatatgt aggtactata cccagtggtc tggttcgtta aaagttactt ttatgtttac 3540
tgggagtttc atggccacag gtaagatgct ggttgcctac tcaccaccgg ggtctgccca 3600
gcccgcgaac agagaaacgg caatgctagg tacacacgtc atatgggatt ttggccttca 3660
gagttcagta tccctggtga ttccttggat tagcaataca cactttcgca cagccaagac 3720
gggaggaaac tacgactact ataccgcggg tgtagttacc ttatggtatc aaacgaacta 3780
tgttgttcca cccgaaacac ccggcgaagc ttacatcata gccatgggag cagcacagga 3840
caattttacc ctgaaaattt gtaaggatac tgacgaggtg acccaacaag ctgttctgca 3900
ataatgaggt accggccggc catttaaata caggcccctt ttcctttgtc gatatcatgt 3960
aattagttat gtcacgctta cattcacgcc ctcctcccac atccgctcta accgaaaagg 4020
aaggagttag acaacctgaa gtctaggtcc ctatttattt tttttaatag ttatgttagt 4080
attaagaacg ttatttatat ttcaaatttt tctttttttt ctgtacaaac gcgtgtacgc 4140
atgtaacatt atactgaaaa ccttgcttga gaaggttttg ggacgctcga aggctttaat 4200
ttgcaagctg gatctaacat ccaaagacga aaggttgaat gaaacctttt tgccatccga 4260
catccacagg tccattctca cacataagtg ccaaacgcaa caggagggga tacactagca 4320
gcagaccgtt gcaaacgcag gacctccact cctcttctcc tcaacaccca cttttgccat 4380
cgaaaaacca gcccagttat tgggcttgat tggagctcgc tcattccaat tccttctatt 4440
aggctactaa caccatgact ttattagcct gtctatcctg gcccccctgg cgaggttcat 4500
gtttgtttat ttccgaatgc aacaagctcc gcattacacc cgaacatcac tccagatgag 4560
ggctttctga gtgtggggtc aaatagtttc atgttcccca aatggcccaa aactgacagt 4620
ttaaacgctg tcttggaacc taatatgaca aaagcgtgat ctcatccaag atgaactaag 4680
tttggttcgt tgaaatgcta acggccagtt ggtcaaaaag aaacttccaa aagtcggcat 4740
accgtttgtc ttgtttggta ttgattgacg aatgctcaaa aataatctca ttaatgctta 4800
gcgcagtctc tctatcgctt ctgaaccccg gtgcacctgt gccgaaacgc aaatggggaa 4860
acacccgctt tttggatgat tatgcattgt ctccacattg tatgcttcca agattctggt 4920
gggaatactg ctgatagcct aacgttcatg atcaaaattt aactgttcta acccctactt 4980
gacagcaata tataaacaga aggaagctgc cctgtcttaa accttttttt ttatcatcat 5040
tattagctta ctttcataat tgcgactggt tccaattgac aagcttttga ttttaacgac 5100
ttttaacgac aacttgagaa gatcaaaaaa caactaatta ttcgaaacgg aattcaccat 5160
gggggaccct gttgaggata taattcacga tgcgttgggt aacacggcgc gcagggctat 5220
atcatcggtt accaatgtcg aaagtgccgc aaatacaaca ccatcgtcgc atcgtctcga 5280
gactgggaga gtccctgcac tacaagccgc cgagacgggg gccacgtcca acgcaacgga 5340
cgaaaatatg atagaaacga ggtgtgtcgt gaatcggaac ggggttttgg aaacgactat 5400
taaccacttc ttcagcagga gtggactagt aggggtcgtc aaccttactg acggaggcac 5460
cgacaccact ggctatgcta cctgggatat cgacattatg ggtttcgtac aactacgtcg 5520
taaatgcgag atgtttacat atatgaggtt caacgctgag tttacatttg tcaccacgac 5580
aaaaaacggc gaggcccgac cgtatatgct tcagtacatg tatgtgcccc ccggtgctcc 5640
aaaaccaact ggaagagacg cattccaatg gcaaactgca acgaatccgt ccgtgtttgt 5700
aaagctcact gatccgcctg ctcaagtttc cgtaccgttc atgtcacccg cttccgccta 5760
tcaatggttc tatgatggat atcccacctt cggacaacac cctgaaacgt ccaatactac 5820
ttatggctta tgtccgaata atatgatggg tacgttcgct gtacgggtag tttcacgaga 5880
agcaagccag ttaaaacttc aaacacgggt atacatgaag ttgaaacatg tgcgggcgtg 5940
ggtgcctcgc cctatacgta gccagccata cctgctcaaa aattttccga attatgactc 6000
ttcgaaggtt acgaactcag ctcgcgaccg atcgtcgatc aaacaagcga acatgtaatg 6060
aggtaccggc cggccattta aatacaggcc ccttttcctt tgtcgatatc atgtaattag 6120
ttatgtcacg cttacattca cgccctcctc ccacatccgc tctaaccgaa aaggaaggag 6180
ttagacaacc tgaagtctag gtccctattt atttttttta atagttatgt tagtattaag 6240
aacgttattt atatttcaaa tttttctttt ttttctgtac aaacgcgtgt acgcatgtaa 6300
cattatactg aaaaccttgc ttgagaaggt tttgggacgc tcgaaggctt taatttgcaa 6360
gctggatccg cggccgcctt ccaaactctc atggattctc aggtaatagg tattctagga 6420
ggaggccagc taggccgaat gattgttgag gccgctagca ggctcaatat caagaccgtg 6480
attcttgatg atggtttttc acctgctaag cacattaatg ctgcgcaaga ccacatcgac 6540
ggatcattca aagatgagga ggctatcgcc aagttagctg ccaaatgtga tgttctcact 6600
gtagagattg agcatgtcaa cacagatgct ctaaagagag ttcaagacag aactggaatc 6660
aagatatatc ctttaccaga gacaatcgaa ctaatcaagg ataagtactt gcaaaaggaa 6720
catttgatca agcacaacat ttcggtgaca aagtctcagg gtatagaatc taatgaaaag 6780
gcgctgcttt tgtttggaga agagaatgga tttccatatc tgttgaagtc ccggactatg 6840
gcttatgatg gaagaggcaa ttttgtagtg gagtctaaag aggacatcag taaggcatta 6900
gagttcttga aagatcgtcc attgtatgcc gagaagtttg ctccttttgt taaagaatta 6960
gcggtaatgg ttgtgagatc actggaaggc gaagtattct cctacccaac cgtagaaact 7020
gtgcacaagg acaatatctg tcatattgtg tatgctccgg ccagagttaa tgacaccatc 7080
caaaagaaag ctcaaatatt agctgaaaac actgtgaaga ctttcccagg cgctggaatc 7140
ttcggagttg agatgttcct attgtctgat ggagaacttc ttgtaaatga gattgctcca 7200
aggccccaca attctggtca ctatacaatc gatgcatgtg taacatctca gttcgaagca 7260
catgtaagag ccataactgg tctgccaatg ccactagatt tcaccaaact atctacttcc 7320
aacaccaacg ctattatgct caatgttttg ggtgctgaaa aatctcacgg ggaattagag 7380
ttttgtagaa gagccttaga aacacccggt gcttctgtat atctgtacgg aaagaccacc 7440
cgattggctc gtaagatggg tcatatcaac ataataggat cttccatgtt ggaagcagaa 7500
caaaagttag agtacattct agaagaatca acccacttac catccagtac tgtatcagct 7560
gacactaaac cgttggttgg agttatcatg ggttcagact ctgatctacc tgtgatttcg 7620
aaaggttgcg atattttaaa acagtttggt gttccattcg aagttactat tgtctctgct 7680
catagaacac cacagagaat gaccagatat gcctttgaag ccgctagtag aggtatcaag 7740
gctatcattg caggtgctgg tggtgctgct catcttccag gaatggttgc tgccatgact 7800
ccgttgccag tcattggtgt tcctgtcaag ggctctacgt tggatggtgt agactcgcta 7860
cactcgattg tccaaatgcc tagaggtgtt cctgtggcta cggttgctat caacaacgcc 7920
accaatgccg ctctgttggc catcaggatt ttaggtacaa ttgaccacaa atggcaaaag 7980
gaaatgtcca agtatatgaa tgcaatggag accgaagtgt tggggaaggc atccaacttg 8040
gaatctgaag ggtatgaatc ctatttgaag aatcgtcttt gaatttagta ttgtttttta 8100
atagatgtat atataatagt acacgtaact tatctattcc attcataatt ttattttaaa 8160
ggttcggtag aaatttgtcc tccaaaaagt tggttagagc ctggcagttt tgataggcat 8220
tattatagat tgggtaatat ttaccctgca cctggaggaa ctttgcaaag agcctcatgt 8280
gcggcgcgcc aggccataat ggccaaacgg tttctcaatt actatatact actaaccatt 8340
tacctgtagc gtatttcttt tccctcttcg cgaaagctca agggcatctt cttgactcat 8400
gaaaaatatc tggatttctt ctgacagatc atcacccttg agcccaactc tctagcctat 8460
gagtgtaagt gatagtcatc ttgcaacaga ttattttgga acgcaactaa caaagcagat 8520
acacccttca gcagaatcct ttctggatat tgtgaagaat gatcgccaaa gtcacagtcc 8580
tgagacagtt cctaatcttt accccattta caagttcatc caatcagact tcttaacgcc 8640
tcatctggct tatatcaagc ttaccaacag ttcagaaact cccagtccaa gtttcttgct 8700
tgaaagtgcg aagaatggtg acaccgttga caggtacacc tttatgggac attcccccag 8760
aaaaataatc aagactgggc ctttagaggg tgctgaagtt gaccccttgg tgcttctgga 8820
aaaagaactg aagggcacca gacaagcgca acttcctggt attcctcgtc taagtggtgg 8880
tgccatagga tacatctcgt acgattgtat taagtacttt gaaccaaaaa ctgaaagaaa 8940
actgaaagat gttttgcaac ttccggaagc agctttgatg ttgttcgaca cgatcgtggc 9000
ttttgacaat gtttatcaaa gattccaggt aattggaaac gtttctctat ccgttgatga 9060
ctcggacgaa gctattcttg agaaatatta taagacaaga gaagaagtgg aaaagatcag 9120
taaagtggta tttgacaata aaactgttcc ctactatgaa cagaaagata ttattcaagg 9180
ccaaacgttc acctctaata ttggtcagga agggtatgaa aaccatgttc gcaagctgaa 9240
agaacatatt ctgaaaggag acatcttcca agctgttccc tctcaaaggg tagccaggcc 9300
gacctcattg caccctttca acatctatcg tcatttgaga actgtcaatc cttctccata 9360
catgttctat attgactatc tagacttcca agttgttggt gcttcacctg aattactagt 9420
taaatccgac aacaacaaca aaatcatcac acatcctatt gctggaactc ttcccagagg 9480
taaaactatc gaagaggacg acaattatgc taagcaattg aagtcgtctt tgaaagacag 9540
ggccgagcac gtcatgctgg tagatttggc cagaaatgat attaaccgtg tgtgtgagcc 9600
caccagtacc acggttgatc gtttattgac tgtggagaga ttttctcatg tgatgcatct 9660
tgtgtcagaa gtcagtggaa cattgagacc aaacaagact cgcttcgatg ctttcagatc 9720
cattttccca gcaggaaccg tctccggtgc tccgaaggta agagcaatgc aactcatagg 9780
agaattggaa ggagaaaaga gaggtgttta tgcgggggcc gtaggacact ggtcgtacga 9840
tggaaaatcg atggacacat gtattgcctt aagaacaatg gtcgtcaagg acggtgtcgc 9900
ttaccttcaa gccggaggtg gaattgtcta cgattctgac ccctatgacg agtacatcga 9960
aaccatgaac aaaatgagat ccaacaataa caccatcttg gaggctgaga aaatctggac 10020
cgataggttg gccagagacg agaatcaaag tgaatccgaa gaaaacgatc aatgaacgga 10080
ggacgtaagt aggaatttat ggtttggcca taatggccta gcttggcgta atcatggtca 10140
tagctgtttc ctgtgtgaaa ttgttatccg ctcacaattc cacacaacat acgagccgga 10200
agcataaagt gtaaagcctg gggtgcctaa tgagtgagct aactcacatt aattgcgttg 10260
cgctcactgc ccgctttcca gtcgggaaac ctgtcgtgcc agctgcatta atgaatcggc 10320
caacgcgcgg ggagaggcgg tttgcgtatt gggcgctctt ccgcttcctc gctcactgac 10380
tcgctgcgct cggtcgttcg gctgcggcga gcggtatcag ctcactcaaa ggcggtaata 10440
cggttatcca cagaatcagg ggataacgca ggaaagaaca tgtgagcaaa aggccagcaa 10500
aaggccagga accgtaaaaa ggccgcgttg ctggcgtttt tccataggct ccgcccccct 10560
gacgagcatc acaaaaatcg acgctcaagt cagaggtggc gaaacccgac aggactataa 10620
agataccagg cgtttccccc tggaagctcc ctcgtgcgct ctcctgttcc gaccctgccg 10680
cttaccggat acctgtccgc ctttctccct tcgggaagcg tggcgctttc tcatagctca 10740
cgctgtaggt atctcagttc ggtgtaggtc gttcgctcca agctgggctg tgtgcacgaa 10800
ccccccgttc agcccgaccg ctgcgcctta tccggtaact atcgtcttga gtccaacccg 10860
gtaagacacg acttatcgcc actggcagca gccactggta acaggattag cagagcgagg 10920
tatgtaggcg gtgctacaga gttcttgaag tggtggccta actacggcta cactagaagg 10980
acagtatttg gtatctgcgc tctgctgaag ccagttacct tcggaaaaag agttggtagc 11040
tcttgatccg gcaaacaaac caccgctggt agcggtggtt tttttgtttg caagcagcag 11100
attacgcgca gaaaaaaagg atctcaagaa gatcctttga tcttttctac ggggtctgac 11160
gctcagtgga acgaaaactc acgttaaggg attttggtca tgagattatc aaaaaggatc 11220
ttcacctaga tccttttaaa ttaaaaatga agttttaaat caatctaaag tatatatgag 11280
taaacttggt ctgacagtta ccaatgctta atcagtgagg cacctatctc agcgatctgt 11340
ctatttcgtt catccatagt tgcctgactc cccgtcgtgt agataactac gatacgggag 11400
ggcttaccat ctggccccag tgctgcaatg ataccgcgag acccacgctc accggctcca 11460
gatttatcag caataaacca gccagccgga agggccgagc gcagaagtgg tcctgcaact 11520
ttatccgcct ccatccagtc tattaattgt tgccgggaag ctagagtaag tagttcgcca 11580
gttaatagtt tgcgcaacgt tgttgccatt gctacaggca tcgtggtgtc acgctcgtcg 11640
tttggtatgg cttcattcag ctccggttcc caacgatcaa ggcgagttac atgatccccc 11700
atgttgtgca aaaaagcggt tagctccttc ggtcctccga tcgttgtcag aagtaagttg 11760
gccgcagtgt tatcactcat ggttatggca gcactgcata attctcttac tgtcatgcca 11820
tccgtaagat gcttttctgt gactggtgag tactcaacca agtcattctg agaatagtgt 11880
atgcggcgac cgagttgctc ttgcccggcg tcaatacggg ataataccgc gccacatagc 11940
agaactttaa aagtgctcat cattggaaaa cgttcttcgg ggcgaaaact ctcaaggatc 12000
ttaccgctgt tgagatccag ttcgatgtaa cccactcgtg cacccaactg atcttcagca 12060
tcttttactt tcaccagcgt ttctgggtga gcaaaaacag gaaggcaaaa tgccgcaaaa 12120
aagggaataa gggcgacacg gaaatgttga atactcatac tcttcctttt tcaatattat 12180
tgaagcattt atcagggtta ttgtctcatg agcggataca tatttgaatg tatttagaaa 12240
aataaacaaa taggggttcc gcgcacattt ccccgaaaag tgccacctga cgtctaagaa 12300
accattatta tcatgacatt aacctataaa aataggcgta tcacgaggcc ctttcgtctc 12360
gcgcgtttcg gtgatgacgg tgaaaacctc tgacacatgc agctcccgga gacggtcaca 12420
gcttgtctgt aagcggatgc cgggagcaga caagcccgtc agggcgcgtc agcgggtgtt 12480
ggcgggtgtc ggggctggct taactatgcg gcatcagagc agattgtact gagagtgcac 12540
catatgcggt gtgaaatacc gcacagatgc gtaaggagaa aataccgcat caggcgccat 12600
tcgccattca ggctgcgcaa ctgttgggaa gggcgatcgg tgcgggcctc ttcgctatta 12660
cgccagctgg cgaaaggggg atgtgctgca aggcgattaa gttgggtaac gccagggttt 12720
tcccagtcac gacgttgtaa aacgacggcc agtgaattg 12759
<210> 14
<211> 12609
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 14
agatctaaca tccaaagacg aaaggttgaa tgaaaccttt ttgccatccg acatccacag 60
gtccattctc acacataagt gccaaacgca acaggagggg atacactagc agcagaccgt 120
tgcaaacgca ggacctccac tcctcttctc ctcaacaccc acttttgcca tcgaaaaacc 180
agcccagtta ttgggcttga ttggagctcg ctcattccaa ttccttctat taggctacta 240
acaccatgac tttattagcc tgtctatcct ggcccccctg gcgaggttca tgtttgttta 300
tttccgaatg caacaagctc cgcattacac ccgaacatca ctccagatga gggctttctg 360
agtgtggggt caaatagttt catgttcccc aaatggccca aaactgacag tttaaacgct 420
gtcttggaac ctaatatgac aaaagcgtga tctcatccaa gatgaactaa gtttggttcg 480
ttgaaatgct aacggccagt tggtcaaaaa gaaacttcca aaagtcggca taccgtttgt 540
cttgtttggt attgattgac gaatgctcaa aaataatctc attaatgctt agcgcagtct 600
ctctatcgct tctgaacccc ggtgcacctg tgccgaaacg caaatgggga aacacccgct 660
ttttggatga ttatgcattg tctccacatt gtatgcttcc aagattctgg tgggaatact 720
gctgatagcc taacgttcat gatcaaaatt taactgttct aacccctact tgacagcaat 780
atataaacag aaggaagctg ccctgtctta aacctttttt tttatcatca ttattagctt 840
actttcataa ttgcgactgg ttccaattga caagcttttg attttaacga cttttaacga 900
caacttgaga agatcaaaaa acaactaatt attcgaaacg gaattcacca tgggcgctca 960
ggtaagcact cagaaatccg gttcacacga aaccggaaac gtagccaccg gtgggtctac 1020
gatcaatttt acaaatataa attattataa ggattcttac gcagcctccg caaccagaca 1080
agactttacc caggacccca aaaaattcac ccaaccagta ttggattcga ttagagaact 1140
cagcgcgccc ttaaatagtc cttcagttga ggcatgcgga tacagcgata gagtggcgca 1200
actaacagtc ggcaacagct ccatcacgac tcaggaggca gccaacatcg tcctcgctta 1260
tggggagtgg cccgagtact gtcctgatac tgacgccaca gcagtcgata agcctacacg 1320
gcctgatgtg tcggttaatc gcttctacac tcttgatagt aagatgtggc aggagaactc 1380
tacaggttgg tattggaaat tcccggacgt cttaaataag actggcgtgt tcgggcagaa 1440
tgctcagttc cactacctgt accgctcagg gttttgcctt catgttcaat gtaacgccag 1500
taagtttcat cagggcgcct tactagtagc ggtgatcccc gaatttgtga ttgcggggcg 1560
aggttcaaat acgaaaccga atgaggcgcc acatcccgga ttcacaacaa ccttcccagg 1620
gactactgga gctacttttc atgacccata cgtgctagac tccggggtgc cactctctca 1680
ggccctaatt tatcctcatc aatggattaa tttgcgaacg aataactgcg ctacagtgat 1740
cgtcccgtac attaatgctg ttccttttga tagcgctatc aaccactcta acttcggcct 1800
catcgttatc ccggtgagtc ctctgaagta tagttcaggt gcgacgaccg caattccaat 1860
aactattacg atagctccgt taaatagcga gttcggtggt ctgcgacagg cagtctcgca 1920
gtaatgaggt accggccggc catttaaata caggcccctt ttcctttgtc gatatcatgt 1980
aattagttat gtcacgctta cattcacgcc ctcctcccac atccgctcta accgaaaagg 2040
aaggagttag acaacctgaa gtctaggtcc ctatttattt tttttaatag ttatgttagt 2100
attaagaacg ttatttatat ttcaaatttt tctttttttt ctgtacaaac gcgtgtacgc 2160
atgtaacatt atactgaaaa ccttgcttga gaaggttttg ggacgctcga aggctttaat 2220
ttgcaagctg gatctaacat ccaaagacga aaggttgaat gaaacctttt tgccatccga 2280
catccacagg tccattctca cacataagtg ccaaacgcaa caggagggga tacactagca 2340
gcagaccgtt gcaaacgcag gacctccact cctcttctcc tcaacaccca cttttgccat 2400
cgaaaaacca gcccagttat tgggcttgat tggagctcgc tcattccaat tccttctatt 2460
aggctactaa caccatgact ttattagcct gtctatcctg gcccccctgg cgaggttcat 2520
gtttgtttat ttccgaatgc aacaagctcc gcattacacc cgaacatcac tccagatgag 2580
ggctttctga gtgtggggtc aaatagtttc atgttcccca aatggcccaa aactgacagt 2640
ttaaacgctg tcttggaacc taatatgaca aaagcgtgat ctcatccaag atgaactaag 2700
tttggttcgt tgaaatgcta acggccagtt ggtcaaaaag aaacttccaa aagtcggcat 2760
accgtttgtc ttgtttggta ttgattgacg aatgctcaaa aataatctca ttaatgctta 2820
gcgcagtctc tctatcgctt ctgaaccccg gtgcacctgt gccgaaacgc aaatggggaa 2880
acacccgctt tttggatgat tatgcattgt ctccacattg tatgcttcca agattctggt 2940
gggaatactg ctgatagcct aacgttcatg atcaaaattt aactgttcta acccctactt 3000
gacagcaata tataaacaga aggaagctgc cctgtcttaa accttttttt ttatcatcat 3060
tattagctta ctttcataat tgcgactggt tccaattgac aagcttttga ttttaacgac 3120
ttttaacgac aacttgagaa gatcaaaaaa caactaatta ttcgaaacgg aattcaccat 3180
gggcatacca gcagagctga ggccgggaac caaccaattt ctcacaacgg acgatgatac 3240
agcggccccc atccttccag gcttcacacc tacccccacc atacatatcc cgggcgaagt 3300
ccactctctc ttggaacttt gccgtgtcga aactatcttg gaggtgaaca acacgactga 3360
agcaacagga ctcacgcgtc ttttaatacc tgtctcttcg caaaacaagg cggacgagtt 3420
atgcgcggcc tttatggtcg atccgggacg gattggccca tggcaatcaa ctctagtagg 3480
tcagatatgt aggtactata cccagtggtc tggttcgtta aaagttactt ttatgtttac 3540
tgggagtttc atggccacag gtaagatgct ggttgcctac tcaccaccgg ggtctgccca 3600
gcccgcgaac agagaaacgg caatgctagg tacacacgtc atatgggatt ttggccttca 3660
gagttcagta tccctggtga ttccttggat tagcaataca cactttcgca cagccaagac 3720
gggaggaaac tacgactact ataccgcggg tgtagttacc ttatggtatc aaacgaacta 3780
tgttgttcca cccgaaacac ccggcgaagc ttacatcata gccatgggag cagcacagga 3840
caattttacc ctgaaaattt gtaaggatac tgacgaggtg acccaacaag ctgttctgca 3900
ataatgaggt accggccggc catttaaata caggcccctt ttcctttgtc gatatcatgt 3960
aattagttat gtcacgctta cattcacgcc ctcctcccac atccgctcta accgaaaagg 4020
aaggagttag acaacctgaa gtctaggtcc ctatttattt tttttaatag ttatgttagt 4080
attaagaacg ttatttatat ttcaaatttt tctttttttt ctgtacaaac gcgtgtacgc 4140
atgtaacatt atactgaaaa ccttgcttga gaaggttttg ggacgctcga aggctttaat 4200
ttgcaagctg gatctaacat ccaaagacga aaggttgaat gaaacctttt tgccatccga 4260
catccacagg tccattctca cacataagtg ccaaacgcaa caggagggga tacactagca 4320
gcagaccgtt gcaaacgcag gacctccact cctcttctcc tcaacaccca cttttgccat 4380
cgaaaaacca gcccagttat tgggcttgat tggagctcgc tcattccaat tccttctatt 4440
aggctactaa caccatgact ttattagcct gtctatcctg gcccccctgg cgaggttcat 4500
gtttgtttat ttccgaatgc aacaagctcc gcattacacc cgaacatcac tccagatgag 4560
ggctttctga gtgtggggtc aaatagtttc atgttcccca aatggcccaa aactgacagt 4620
ttaaacgctg tcttggaacc taatatgaca aaagcgtgat ctcatccaag atgaactaag 4680
tttggttcgt tgaaatgcta acggccagtt ggtcaaaaag aaacttccaa aagtcggcat 4740
accgtttgtc ttgtttggta ttgattgacg aatgctcaaa aataatctca ttaatgctta 4800
gcgcagtctc tctatcgctt ctgaaccccg gtgcacctgt gccgaaacgc aaatggggaa 4860
acacccgctt tttggatgat tatgcattgt ctccacattg tatgcttcca agattctggt 4920
gggaatactg ctgatagcct aacgttcatg atcaaaattt aactgttcta acccctactt 4980
gacagcaata tataaacaga aggaagctgc cctgtcttaa accttttttt ttatcatcat 5040
tattagctta ctttcataat tgcgactggt tccaattgac aagcttttga ttttaacgac 5100
ttttaacgac aacttgagaa gatcaaaaaa caactaatta ttcgaaacgg aattcaccat 5160
ggagacgggg gccacgtcca acgcaacgga cgaaaatatg atagaaacga ggtgtgtcgt 5220
gaatcggaac ggggttttgg aaacgactat taaccacttc ttcagcagga gtggactagt 5280
aggggtcgtc aaccttactg acggaggcac cgacaccact ggctatgcta cctgggatat 5340
cgacattatg ggtttcgtac aactacgtcg taaatgcgag atgtttacat atatgaggtt 5400
caacgctgag tttacatttg tcaccacgac aaaaaacggc gaggcccgac cgtatatgct 5460
tcagtacatg tatgtgcccc ccggtgctcc aaaaccaact ggaagagacg cattccaatg 5520
gcaaactgca acgaatccgt ccgtgtttgt aaagctcact gatccgcctg ctcaagtttc 5580
cgtaccgttc atgtcacccg cttccgccta tcaatggttc tatgatggat atcccacctt 5640
cggacaacac cctgaaacgt ccaatactac ttatggctta tgtccgaata atatgatggg 5700
tacgttcgct gtacgggtag tttcacgaga agcaagccag ttaaaacttc aaacacgggt 5760
atacatgaag ttgaaacatg tgcgggcgtg ggtgcctcgc cctatacgta gccagccata 5820
cctgctcaaa aattttccga attatgactc ttcgaaggtt acgaactcag ctcgcgaccg 5880
atcgtcgatc aaacaagcga acatgtaatg aggtaccggc cggccattta aatacaggcc 5940
ccttttcctt tgtcgatatc atgtaattag ttatgtcacg cttacattca cgccctcctc 6000
ccacatccgc tctaaccgaa aaggaaggag ttagacaacc tgaagtctag gtccctattt 6060
atttttttta atagttatgt tagtattaag aacgttattt atatttcaaa tttttctttt 6120
ttttctgtac aaacgcgtgt acgcatgtaa cattatactg aaaaccttgc ttgagaaggt 6180
tttgggacgc tcgaaggctt taatttgcaa gctggatccg cggccgcctt ccaaactctc 6240
atggattctc aggtaatagg tattctagga ggaggccagc taggccgaat gattgttgag 6300
gccgctagca ggctcaatat caagaccgtg attcttgatg atggtttttc acctgctaag 6360
cacattaatg ctgcgcaaga ccacatcgac ggatcattca aagatgagga ggctatcgcc 6420
aagttagctg ccaaatgtga tgttctcact gtagagattg agcatgtcaa cacagatgct 6480
ctaaagagag ttcaagacag aactggaatc aagatatatc ctttaccaga gacaatcgaa 6540
ctaatcaagg ataagtactt gcaaaaggaa catttgatca agcacaacat ttcggtgaca 6600
aagtctcagg gtatagaatc taatgaaaag gcgctgcttt tgtttggaga agagaatgga 6660
tttccatatc tgttgaagtc ccggactatg gcttatgatg gaagaggcaa ttttgtagtg 6720
gagtctaaag aggacatcag taaggcatta gagttcttga aagatcgtcc attgtatgcc 6780
gagaagtttg ctccttttgt taaagaatta gcggtaatgg ttgtgagatc actggaaggc 6840
gaagtattct cctacccaac cgtagaaact gtgcacaagg acaatatctg tcatattgtg 6900
tatgctccgg ccagagttaa tgacaccatc caaaagaaag ctcaaatatt agctgaaaac 6960
actgtgaaga ctttcccagg cgctggaatc ttcggagttg agatgttcct attgtctgat 7020
ggagaacttc ttgtaaatga gattgctcca aggccccaca attctggtca ctatacaatc 7080
gatgcatgtg taacatctca gttcgaagca catgtaagag ccataactgg tctgccaatg 7140
ccactagatt tcaccaaact atctacttcc aacaccaacg ctattatgct caatgttttg 7200
ggtgctgaaa aatctcacgg ggaattagag ttttgtagaa gagccttaga aacacccggt 7260
gcttctgtat atctgtacgg aaagaccacc cgattggctc gtaagatggg tcatatcaac 7320
ataataggat cttccatgtt ggaagcagaa caaaagttag agtacattct agaagaatca 7380
acccacttac catccagtac tgtatcagct gacactaaac cgttggttgg agttatcatg 7440
ggttcagact ctgatctacc tgtgatttcg aaaggttgcg atattttaaa acagtttggt 7500
gttccattcg aagttactat tgtctctgct catagaacac cacagagaat gaccagatat 7560
gcctttgaag ccgctagtag aggtatcaag gctatcattg caggtgctgg tggtgctgct 7620
catcttccag gaatggttgc tgccatgact ccgttgccag tcattggtgt tcctgtcaag 7680
ggctctacgt tggatggtgt agactcgcta cactcgattg tccaaatgcc tagaggtgtt 7740
cctgtggcta cggttgctat caacaacgcc accaatgccg ctctgttggc catcaggatt 7800
ttaggtacaa ttgaccacaa atggcaaaag gaaatgtcca agtatatgaa tgcaatggag 7860
accgaagtgt tggggaaggc atccaacttg gaatctgaag ggtatgaatc ctatttgaag 7920
aatcgtcttt gaatttagta ttgtttttta atagatgtat atataatagt acacgtaact 7980
tatctattcc attcataatt ttattttaaa ggttcggtag aaatttgtcc tccaaaaagt 8040
tggttagagc ctggcagttt tgataggcat tattatagat tgggtaatat ttaccctgca 8100
cctggaggaa ctttgcaaag agcctcatgt gcggcgcgcc aggccataat ggccaaacgg 8160
tttctcaatt actatatact actaaccatt tacctgtagc gtatttcttt tccctcttcg 8220
cgaaagctca agggcatctt cttgactcat gaaaaatatc tggatttctt ctgacagatc 8280
atcacccttg agcccaactc tctagcctat gagtgtaagt gatagtcatc ttgcaacaga 8340
ttattttgga acgcaactaa caaagcagat acacccttca gcagaatcct ttctggatat 8400
tgtgaagaat gatcgccaaa gtcacagtcc tgagacagtt cctaatcttt accccattta 8460
caagttcatc caatcagact tcttaacgcc tcatctggct tatatcaagc ttaccaacag 8520
ttcagaaact cccagtccaa gtttcttgct tgaaagtgcg aagaatggtg acaccgttga 8580
caggtacacc tttatgggac attcccccag aaaaataatc aagactgggc ctttagaggg 8640
tgctgaagtt gaccccttgg tgcttctgga aaaagaactg aagggcacca gacaagcgca 8700
acttcctggt attcctcgtc taagtggtgg tgccatagga tacatctcgt acgattgtat 8760
taagtacttt gaaccaaaaa ctgaaagaaa actgaaagat gttttgcaac ttccggaagc 8820
agctttgatg ttgttcgaca cgatcgtggc ttttgacaat gtttatcaaa gattccaggt 8880
aattggaaac gtttctctat ccgttgatga ctcggacgaa gctattcttg agaaatatta 8940
taagacaaga gaagaagtgg aaaagatcag taaagtggta tttgacaata aaactgttcc 9000
ctactatgaa cagaaagata ttattcaagg ccaaacgttc acctctaata ttggtcagga 9060
agggtatgaa aaccatgttc gcaagctgaa agaacatatt ctgaaaggag acatcttcca 9120
agctgttccc tctcaaaggg tagccaggcc gacctcattg caccctttca acatctatcg 9180
tcatttgaga actgtcaatc cttctccata catgttctat attgactatc tagacttcca 9240
agttgttggt gcttcacctg aattactagt taaatccgac aacaacaaca aaatcatcac 9300
acatcctatt gctggaactc ttcccagagg taaaactatc gaagaggacg acaattatgc 9360
taagcaattg aagtcgtctt tgaaagacag ggccgagcac gtcatgctgg tagatttggc 9420
cagaaatgat attaaccgtg tgtgtgagcc caccagtacc acggttgatc gtttattgac 9480
tgtggagaga ttttctcatg tgatgcatct tgtgtcagaa gtcagtggaa cattgagacc 9540
aaacaagact cgcttcgatg ctttcagatc cattttccca gcaggaaccg tctccggtgc 9600
tccgaaggta agagcaatgc aactcatagg agaattggaa ggagaaaaga gaggtgttta 9660
tgcgggggcc gtaggacact ggtcgtacga tggaaaatcg atggacacat gtattgcctt 9720
aagaacaatg gtcgtcaagg acggtgtcgc ttaccttcaa gccggaggtg gaattgtcta 9780
cgattctgac ccctatgacg agtacatcga aaccatgaac aaaatgagat ccaacaataa 9840
caccatcttg gaggctgaga aaatctggac cgataggttg gccagagacg agaatcaaag 9900
tgaatccgaa gaaaacgatc aatgaacgga ggacgtaagt aggaatttat ggtttggcca 9960
taatggccta gcttggcgta atcatggtca tagctgtttc ctgtgtgaaa ttgttatccg 10020
ctcacaattc cacacaacat acgagccgga agcataaagt gtaaagcctg gggtgcctaa 10080
tgagtgagct aactcacatt aattgcgttg cgctcactgc ccgctttcca gtcgggaaac 10140
ctgtcgtgcc agctgcatta atgaatcggc caacgcgcgg ggagaggcgg tttgcgtatt 10200
gggcgctctt ccgcttcctc gctcactgac tcgctgcgct cggtcgttcg gctgcggcga 10260
gcggtatcag ctcactcaaa ggcggtaata cggttatcca cagaatcagg ggataacgca 10320
ggaaagaaca tgtgagcaaa aggccagcaa aaggccagga accgtaaaaa ggccgcgttg 10380
ctggcgtttt tccataggct ccgcccccct gacgagcatc acaaaaatcg acgctcaagt 10440
cagaggtggc gaaacccgac aggactataa agataccagg cgtttccccc tggaagctcc 10500
ctcgtgcgct ctcctgttcc gaccctgccg cttaccggat acctgtccgc ctttctccct 10560
tcgggaagcg tggcgctttc tcatagctca cgctgtaggt atctcagttc ggtgtaggtc 10620
gttcgctcca agctgggctg tgtgcacgaa ccccccgttc agcccgaccg ctgcgcctta 10680
tccggtaact atcgtcttga gtccaacccg gtaagacacg acttatcgcc actggcagca 10740
gccactggta acaggattag cagagcgagg tatgtaggcg gtgctacaga gttcttgaag 10800
tggtggccta actacggcta cactagaagg acagtatttg gtatctgcgc tctgctgaag 10860
ccagttacct tcggaaaaag agttggtagc tcttgatccg gcaaacaaac caccgctggt 10920
agcggtggtt tttttgtttg caagcagcag attacgcgca gaaaaaaagg atctcaagaa 10980
gatcctttga tcttttctac ggggtctgac gctcagtgga acgaaaactc acgttaaggg 11040
attttggtca tgagattatc aaaaaggatc ttcacctaga tccttttaaa ttaaaaatga 11100
agttttaaat caatctaaag tatatatgag taaacttggt ctgacagtta ccaatgctta 11160
atcagtgagg cacctatctc agcgatctgt ctatttcgtt catccatagt tgcctgactc 11220
cccgtcgtgt agataactac gatacgggag ggcttaccat ctggccccag tgctgcaatg 11280
ataccgcgag acccacgctc accggctcca gatttatcag caataaacca gccagccgga 11340
agggccgagc gcagaagtgg tcctgcaact ttatccgcct ccatccagtc tattaattgt 11400
tgccgggaag ctagagtaag tagttcgcca gttaatagtt tgcgcaacgt tgttgccatt 11460
gctacaggca tcgtggtgtc acgctcgtcg tttggtatgg cttcattcag ctccggttcc 11520
caacgatcaa ggcgagttac atgatccccc atgttgtgca aaaaagcggt tagctccttc 11580
ggtcctccga tcgttgtcag aagtaagttg gccgcagtgt tatcactcat ggttatggca 11640
gcactgcata attctcttac tgtcatgcca tccgtaagat gcttttctgt gactggtgag 11700
tactcaacca agtcattctg agaatagtgt atgcggcgac cgagttgctc ttgcccggcg 11760
tcaatacggg ataataccgc gccacatagc agaactttaa aagtgctcat cattggaaaa 11820
cgttcttcgg ggcgaaaact ctcaaggatc ttaccgctgt tgagatccag ttcgatgtaa 11880
cccactcgtg cacccaactg atcttcagca tcttttactt tcaccagcgt ttctgggtga 11940
gcaaaaacag gaaggcaaaa tgccgcaaaa aagggaataa gggcgacacg gaaatgttga 12000
atactcatac tcttcctttt tcaatattat tgaagcattt atcagggtta ttgtctcatg 12060
agcggataca tatttgaatg tatttagaaa aataaacaaa taggggttcc gcgcacattt 12120
ccccgaaaag tgccacctga cgtctaagaa accattatta tcatgacatt aacctataaa 12180
aataggcgta tcacgaggcc ctttcgtctc gcgcgtttcg gtgatgacgg tgaaaacctc 12240
tgacacatgc agctcccgga gacggtcaca gcttgtctgt aagcggatgc cgggagcaga 12300
caagcccgtc agggcgcgtc agcgggtgtt ggcgggtgtc ggggctggct taactatgcg 12360
gcatcagagc agattgtact gagagtgcac catatgcggt gtgaaatacc gcacagatgc 12420
gtaaggagaa aataccgcat caggcgccat tcgccattca ggctgcgcaa ctgttgggaa 12480
gggcgatcgg tgcgggcctc ttcgctatta cgccagctgg cgaaaggggg atgtgctgca 12540
aggcgattaa gttgggtaac gccagggttt tcccagtcac gacgttgtaa aacgacggcc 12600
agtgaattg 12609
<210> 15
<211> 12543
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 15
agatctaaca tccaaagacg aaaggttgaa tgaaaccttt ttgccatccg acatccacag 60
gtccattctc acacataagt gccaaacgca acaggagggg atacactagc agcagaccgt 120
tgcaaacgca ggacctccac tcctcttctc ctcaacaccc acttttgcca tcgaaaaacc 180
agcccagtta ttgggcttga ttggagctcg ctcattccaa ttccttctat taggctacta 240
acaccatgac tttattagcc tgtctatcct ggcccccctg gcgaggttca tgtttgttta 300
tttccgaatg caacaagctc cgcattacac ccgaacatca ctccagatga gggctttctg 360
agtgtggggt caaatagttt catgttcccc aaatggccca aaactgacag tttaaacgct 420
gtcttggaac ctaatatgac aaaagcgtga tctcatccaa gatgaactaa gtttggttcg 480
ttgaaatgct aacggccagt tggtcaaaaa gaaacttcca aaagtcggca taccgtttgt 540
cttgtttggt attgattgac gaatgctcaa aaataatctc attaatgctt agcgcagtct 600
ctctatcgct tctgaacccc ggtgcacctg tgccgaaacg caaatgggga aacacccgct 660
ttttggatga ttatgcattg tctccacatt gtatgcttcc aagattctgg tgggaatact 720
gctgatagcc taacgttcat gatcaaaatt taactgttct aacccctact tgacagcaat 780
atataaacag aaggaagctg ccctgtctta aacctttttt tttatcatca ttattagctt 840
actttcataa ttgcgactgg ttccaattga caagcttttg attttaacga cttttaacga 900
caacttgaga agatcaaaaa acaactaatt attcgaaacg gaattcacca tgggcgctca 960
ggtaagcact cagaaatccg gttcacacga aaccggaaac gtagccaccg gtgggtctac 1020
gatcaatttt acaaatataa attattataa ggattcttac gcagcctccg caaccagaca 1080
agactttacc caggacccca aaaaattcac ccaaccagta ttggattcga ttagagaact 1140
cagcgcgccc ttaaatagtc cttcagttga ggcatgcgga tacagcgata gagtggcgca 1200
actaacagtc ggcaacagct ccatcacgac tcaggaggca gccaacatcg tcctcgctta 1260
tggggagtgg cccgagtact gtcctgatac tgacgccaca gcagtcgata agcctacacg 1320
gcctgatgtg tcggttaatc gcttctacac tcttgatagt aagatgtggc aggagaactc 1380
tacaggttgg tattggaaat tcccggacgt cttaaataag actggcgtgt tcgggcagaa 1440
tgctcagttc cactacctgt accgctcagg gttttgcctt catgttcaat gtaacgccag 1500
taagtttcat cagggcgcct tactagtagc ggtgatcccc gaatttgtga ttgcggggcg 1560
aggttcaaat acgaaaccga atgaggcgcc acatcccgga ttcacaacaa ccttcccagg 1620
gactactgga gctacttttc atgacccata cgtgctagac tccggggtgc cactctctca 1680
ggccctaatt tatcctcatc aatggattaa tttgcgaacg aataactgcg ctacagtgat 1740
cgtcccgtac attaatgctg ttccttttga tagcgctatc aaccactcta acttcggcct 1800
catcgttatc ccggtgagtc ctctgaagta tagttcaggt gcgacgaccg caattccaat 1860
aactattacg atagctccgt taaatagcga gttcggtggt ctgcgacagg cagtctcgca 1920
gtaatgaggt accggccggc catttaaata caggcccctt ttcctttgtc gatatcatgt 1980
aattagttat gtcacgctta cattcacgcc ctcctcccac atccgctcta accgaaaagg 2040
aaggagttag acaacctgaa gtctaggtcc ctatttattt tttttaatag ttatgttagt 2100
attaagaacg ttatttatat ttcaaatttt tctttttttt ctgtacaaac gcgtgtacgc 2160
atgtaacatt atactgaaaa ccttgcttga gaaggttttg ggacgctcga aggctttaat 2220
ttgcaagctg gatctaacat ccaaagacga aaggttgaat gaaacctttt tgccatccga 2280
catccacagg tccattctca cacataagtg ccaaacgcaa caggagggga tacactagca 2340
gcagaccgtt gcaaacgcag gacctccact cctcttctcc tcaacaccca cttttgccat 2400
cgaaaaacca gcccagttat tgggcttgat tggagctcgc tcattccaat tccttctatt 2460
aggctactaa caccatgact ttattagcct gtctatcctg gcccccctgg cgaggttcat 2520
gtttgtttat ttccgaatgc aacaagctcc gcattacacc cgaacatcac tccagatgag 2580
ggctttctga gtgtggggtc aaatagtttc atgttcccca aatggcccaa aactgacagt 2640
ttaaacgctg tcttggaacc taatatgaca aaagcgtgat ctcatccaag atgaactaag 2700
tttggttcgt tgaaatgcta acggccagtt ggtcaaaaag aaacttccaa aagtcggcat 2760
accgtttgtc ttgtttggta ttgattgacg aatgctcaaa aataatctca ttaatgctta 2820
gcgcagtctc tctatcgctt ctgaaccccg gtgcacctgt gccgaaacgc aaatggggaa 2880
acacccgctt tttggatgat tatgcattgt ctccacattg tatgcttcca agattctggt 2940
gggaatactg ctgatagcct aacgttcatg atcaaaattt aactgttcta acccctactt 3000
gacagcaata tataaacaga aggaagctgc cctgtcttaa accttttttt ttatcatcat 3060
tattagctta ctttcataat tgcgactggt tccaattgac aagcttttga ttttaacgac 3120
ttttaacgac aacttgagaa gatcaaaaaa caactaatta ttcgaaacgg aattcaccat 3180
gggcatacca gcagagctga ggccgggaac caaccaattt ctcacaacgg acgatgatac 3240
agcggccccc atccttccag gcttcacacc tacccccacc atacatatcc cgggcgaagt 3300
ccactctctc ttggaacttt gccgtgtcga aactatcttg gaggtgaaca acacgactga 3360
agcaacagga ctcacgcgtc ttttaatacc tgtctcttcg caaaacaagg cggacgagtt 3420
atgcgcggcc tttatggtcg atccgggacg gattggccca tggcaatcaa ctctagtagg 3480
tcagatatgt aggtactata cccagtggtc tggttcgtta aaagttactt ttatgtttac 3540
tgggagtttc atggccacag gtaagatgct ggttgcctac tcaccaccgg ggtctgccca 3600
gcccgcgaac agagaaacgg caatgctagg tacacacgtc atatgggatt ttggccttca 3660
gagttcagta tccctggtga ttccttggat tagcaataca cactttcgca cagccaagac 3720
gggaggaaac tacgactact ataccgcggg tgtagttacc ttatggtatc aaacgaacta 3780
tgttgttcca cccgaaacac ccggcgaagc ttacatcata gccatgggag cagcacagga 3840
caattttacc ctgaaaattt gtaaggatac tgacgaggtg acccaacaag ctgttctgca 3900
ataatgaggt accggccggc catttaaata caggcccctt ttcctttgtc gatatcatgt 3960
aattagttat gtcacgctta cattcacgcc ctcctcccac atccgctcta accgaaaagg 4020
aaggagttag acaacctgaa gtctaggtcc ctatttattt tttttaatag ttatgttagt 4080
attaagaacg ttatttatat ttcaaatttt tctttttttt ctgtacaaac gcgtgtacgc 4140
atgtaacatt atactgaaaa ccttgcttga gaaggttttg ggacgctcga aggctttaat 4200
ttgcaagctg gatctaacat ccaaagacga aaggttgaat gaaacctttt tgccatccga 4260
catccacagg tccattctca cacataagtg ccaaacgcaa caggagggga tacactagca 4320
gcagaccgtt gcaaacgcag gacctccact cctcttctcc tcaacaccca cttttgccat 4380
cgaaaaacca gcccagttat tgggcttgat tggagctcgc tcattccaat tccttctatt 4440
aggctactaa caccatgact ttattagcct gtctatcctg gcccccctgg cgaggttcat 4500
gtttgtttat ttccgaatgc aacaagctcc gcattacacc cgaacatcac tccagatgag 4560
ggctttctga gtgtggggtc aaatagtttc atgttcccca aatggcccaa aactgacagt 4620
ttaaacgctg tcttggaacc taatatgaca aaagcgtgat ctcatccaag atgaactaag 4680
tttggttcgt tgaaatgcta acggccagtt ggtcaaaaag aaacttccaa aagtcggcat 4740
accgtttgtc ttgtttggta ttgattgacg aatgctcaaa aataatctca ttaatgctta 4800
gcgcagtctc tctatcgctt ctgaaccccg gtgcacctgt gccgaaacgc aaatggggaa 4860
acacccgctt tttggatgat tatgcattgt ctccacattg tatgcttcca agattctggt 4920
gggaatactg ctgatagcct aacgttcatg atcaaaattt aactgttcta acccctactt 4980
gacagcaata tataaacaga aggaagctgc cctgtcttaa accttttttt ttatcatcat 5040
tattagctta ctttcataat tgcgactggt tccaattgac aagcttttga ttttaacgac 5100
ttttaacgac aacttgagaa gatcaaaaaa caactaatta ttcgaaacgg aattcaccat 5160
gaacggggtt ttggaaacga ctattaacca cttcttcagc aggagtggac tagtaggggt 5220
cgtcaacctt actgacggag gcaccgacac cactggctat gctacctggg atatcgacat 5280
tatgggtttc gtacaactac gtcgtaaatg cgagatgttt acatatatga ggttcaacgc 5340
tgagtttaca tttgtcacca cgacaaaaaa cggcgaggcc cgaccgtata tgcttcagta 5400
catgtatgtg ccccccggtg ctccaaaacc aactggaaga gacgcattcc aatggcaaac 5460
tgcaacgaat ccgtccgtgt ttgtaaagct cactgatccg cctgctcaag tttccgtacc 5520
gttcatgtca cccgcttccg cctatcaatg gttctatgat ggatatccca ccttcggaca 5580
acaccctgaa acgtccaata ctacttatgg cttatgtccg aataatatga tgggtacgtt 5640
cgctgtacgg gtagtttcac gagaagcaag ccagttaaaa cttcaaacac gggtatacat 5700
gaagttgaaa catgtgcggg cgtgggtgcc tcgccctata cgtagccagc catacctgct 5760
caaaaatttt ccgaattatg actcttcgaa ggttacgaac tcagctcgcg accgatcgtc 5820
gatcaaacaa gcgaacatgt aatgaggtac cggccggcca tttaaataca ggcccctttt 5880
cctttgtcga tatcatgtaa ttagttatgt cacgcttaca ttcacgccct cctcccacat 5940
ccgctctaac cgaaaaggaa ggagttagac aacctgaagt ctaggtccct atttattttt 6000
tttaatagtt atgttagtat taagaacgtt atttatattt caaatttttc ttttttttct 6060
gtacaaacgc gtgtacgcat gtaacattat actgaaaacc ttgcttgaga aggttttggg 6120
acgctcgaag gctttaattt gcaagctgga tccgcggccg ccttccaaac tctcatggat 6180
tctcaggtaa taggtattct aggaggaggc cagctaggcc gaatgattgt tgaggccgct 6240
agcaggctca atatcaagac cgtgattctt gatgatggtt tttcacctgc taagcacatt 6300
aatgctgcgc aagaccacat cgacggatca ttcaaagatg aggaggctat cgccaagtta 6360
gctgccaaat gtgatgttct cactgtagag attgagcatg tcaacacaga tgctctaaag 6420
agagttcaag acagaactgg aatcaagata tatcctttac cagagacaat cgaactaatc 6480
aaggataagt acttgcaaaa ggaacatttg atcaagcaca acatttcggt gacaaagtct 6540
cagggtatag aatctaatga aaaggcgctg cttttgtttg gagaagagaa tggatttcca 6600
tatctgttga agtcccggac tatggcttat gatggaagag gcaattttgt agtggagtct 6660
aaagaggaca tcagtaaggc attagagttc ttgaaagatc gtccattgta tgccgagaag 6720
tttgctcctt ttgttaaaga attagcggta atggttgtga gatcactgga aggcgaagta 6780
ttctcctacc caaccgtaga aactgtgcac aaggacaata tctgtcatat tgtgtatgct 6840
ccggccagag ttaatgacac catccaaaag aaagctcaaa tattagctga aaacactgtg 6900
aagactttcc caggcgctgg aatcttcgga gttgagatgt tcctattgtc tgatggagaa 6960
cttcttgtaa atgagattgc tccaaggccc cacaattctg gtcactatac aatcgatgca 7020
tgtgtaacat ctcagttcga agcacatgta agagccataa ctggtctgcc aatgccacta 7080
gatttcacca aactatctac ttccaacacc aacgctatta tgctcaatgt tttgggtgct 7140
gaaaaatctc acggggaatt agagttttgt agaagagcct tagaaacacc cggtgcttct 7200
gtatatctgt acggaaagac cacccgattg gctcgtaaga tgggtcatat caacataata 7260
ggatcttcca tgttggaagc agaacaaaag ttagagtaca ttctagaaga atcaacccac 7320
ttaccatcca gtactgtatc agctgacact aaaccgttgg ttggagttat catgggttca 7380
gactctgatc tacctgtgat ttcgaaaggt tgcgatattt taaaacagtt tggtgttcca 7440
ttcgaagtta ctattgtctc tgctcataga acaccacaga gaatgaccag atatgccttt 7500
gaagccgcta gtagaggtat caaggctatc attgcaggtg ctggtggtgc tgctcatctt 7560
ccaggaatgg ttgctgccat gactccgttg ccagtcattg gtgttcctgt caagggctct 7620
acgttggatg gtgtagactc gctacactcg attgtccaaa tgcctagagg tgttcctgtg 7680
gctacggttg ctatcaacaa cgccaccaat gccgctctgt tggccatcag gattttaggt 7740
acaattgacc acaaatggca aaaggaaatg tccaagtata tgaatgcaat ggagaccgaa 7800
gtgttgggga aggcatccaa cttggaatct gaagggtatg aatcctattt gaagaatcgt 7860
ctttgaattt agtattgttt tttaatagat gtatatataa tagtacacgt aacttatcta 7920
ttccattcat aattttattt taaaggttcg gtagaaattt gtcctccaaa aagttggtta 7980
gagcctggca gttttgatag gcattattat agattgggta atatttaccc tgcacctgga 8040
ggaactttgc aaagagcctc atgtgcggcg cgccaggcca taatggccaa acggtttctc 8100
aattactata tactactaac catttacctg tagcgtattt cttttccctc ttcgcgaaag 8160
ctcaagggca tcttcttgac tcatgaaaaa tatctggatt tcttctgaca gatcatcacc 8220
cttgagccca actctctagc ctatgagtgt aagtgatagt catcttgcaa cagattattt 8280
tggaacgcaa ctaacaaagc agatacaccc ttcagcagaa tcctttctgg atattgtgaa 8340
gaatgatcgc caaagtcaca gtcctgagac agttcctaat ctttacccca tttacaagtt 8400
catccaatca gacttcttaa cgcctcatct ggcttatatc aagcttacca acagttcaga 8460
aactcccagt ccaagtttct tgcttgaaag tgcgaagaat ggtgacaccg ttgacaggta 8520
cacctttatg ggacattccc ccagaaaaat aatcaagact gggcctttag agggtgctga 8580
agttgacccc ttggtgcttc tggaaaaaga actgaagggc accagacaag cgcaacttcc 8640
tggtattcct cgtctaagtg gtggtgccat aggatacatc tcgtacgatt gtattaagta 8700
ctttgaacca aaaactgaaa gaaaactgaa agatgttttg caacttccgg aagcagcttt 8760
gatgttgttc gacacgatcg tggcttttga caatgtttat caaagattcc aggtaattgg 8820
aaacgtttct ctatccgttg atgactcgga cgaagctatt cttgagaaat attataagac 8880
aagagaagaa gtggaaaaga tcagtaaagt ggtatttgac aataaaactg ttccctacta 8940
tgaacagaaa gatattattc aaggccaaac gttcacctct aatattggtc aggaagggta 9000
tgaaaaccat gttcgcaagc tgaaagaaca tattctgaaa ggagacatct tccaagctgt 9060
tccctctcaa agggtagcca ggccgacctc attgcaccct ttcaacatct atcgtcattt 9120
gagaactgtc aatccttctc catacatgtt ctatattgac tatctagact tccaagttgt 9180
tggtgcttca cctgaattac tagttaaatc cgacaacaac aacaaaatca tcacacatcc 9240
tattgctgga actcttccca gaggtaaaac tatcgaagag gacgacaatt atgctaagca 9300
attgaagtcg tctttgaaag acagggccga gcacgtcatg ctggtagatt tggccagaaa 9360
tgatattaac cgtgtgtgtg agcccaccag taccacggtt gatcgtttat tgactgtgga 9420
gagattttct catgtgatgc atcttgtgtc agaagtcagt ggaacattga gaccaaacaa 9480
gactcgcttc gatgctttca gatccatttt cccagcagga accgtctccg gtgctccgaa 9540
ggtaagagca atgcaactca taggagaatt ggaaggagaa aagagaggtg tttatgcggg 9600
ggccgtagga cactggtcgt acgatggaaa atcgatggac acatgtattg ccttaagaac 9660
aatggtcgtc aaggacggtg tcgcttacct tcaagccgga ggtggaattg tctacgattc 9720
tgacccctat gacgagtaca tcgaaaccat gaacaaaatg agatccaaca ataacaccat 9780
cttggaggct gagaaaatct ggaccgatag gttggccaga gacgagaatc aaagtgaatc 9840
cgaagaaaac gatcaatgaa cggaggacgt aagtaggaat ttatggtttg gccataatgg 9900
cctagcttgg cgtaatcatg gtcatagctg tttcctgtgt gaaattgtta tccgctcaca 9960
attccacaca acatacgagc cggaagcata aagtgtaaag cctggggtgc ctaatgagtg 10020
agctaactca cattaattgc gttgcgctca ctgcccgctt tccagtcggg aaacctgtcg 10080
tgccagctgc attaatgaat cggccaacgc gcggggagag gcggtttgcg tattgggcgc 10140
tcttccgctt cctcgctcac tgactcgctg cgctcggtcg ttcggctgcg gcgagcggta 10200
tcagctcact caaaggcggt aatacggtta tccacagaat caggggataa cgcaggaaag 10260
aacatgtgag caaaaggcca gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg 10320
tttttccata ggctccgccc ccctgacgag catcacaaaa atcgacgctc aagtcagagg 10380
tggcgaaacc cgacaggact ataaagatac caggcgtttc cccctggaag ctccctcgtg 10440
cgctctcctg ttccgaccct gccgcttacc ggatacctgt ccgcctttct cccttcggga 10500
agcgtggcgc tttctcatag ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc 10560
tccaagctgg gctgtgtgca cgaacccccc gttcagcccg accgctgcgc cttatccggt 10620
aactatcgtc ttgagtccaa cccggtaaga cacgacttat cgccactggc agcagccact 10680
ggtaacagga ttagcagagc gaggtatgta ggcggtgcta cagagttctt gaagtggtgg 10740
cctaactacg gctacactag aaggacagta tttggtatct gcgctctgct gaagccagtt 10800
accttcggaa aaagagttgg tagctcttga tccggcaaac aaaccaccgc tggtagcggt 10860
ggtttttttg tttgcaagca gcagattacg cgcagaaaaa aaggatctca agaagatcct 10920
ttgatctttt ctacggggtc tgacgctcag tggaacgaaa actcacgtta agggattttg 10980
gtcatgagat tatcaaaaag gatcttcacc tagatccttt taaattaaaa atgaagtttt 11040
aaatcaatct aaagtatata tgagtaaact tggtctgaca gttaccaatg cttaatcagt 11100
gaggcaccta tctcagcgat ctgtctattt cgttcatcca tagttgcctg actccccgtc 11160
gtgtagataa ctacgatacg ggagggctta ccatctggcc ccagtgctgc aatgataccg 11220
cgagacccac gctcaccggc tccagattta tcagcaataa accagccagc cggaagggcc 11280
gagcgcagaa gtggtcctgc aactttatcc gcctccatcc agtctattaa ttgttgccgg 11340
gaagctagag taagtagttc gccagttaat agtttgcgca acgttgttgc cattgctaca 11400
ggcatcgtgg tgtcacgctc gtcgtttggt atggcttcat tcagctccgg ttcccaacga 11460
tcaaggcgag ttacatgatc ccccatgttg tgcaaaaaag cggttagctc cttcggtcct 11520
ccgatcgttg tcagaagtaa gttggccgca gtgttatcac tcatggttat ggcagcactg 11580
cataattctc ttactgtcat gccatccgta agatgctttt ctgtgactgg tgagtactca 11640
accaagtcat tctgagaata gtgtatgcgg cgaccgagtt gctcttgccc ggcgtcaata 11700
cgggataata ccgcgccaca tagcagaact ttaaaagtgc tcatcattgg aaaacgttct 11760
tcggggcgaa aactctcaag gatcttaccg ctgttgagat ccagttcgat gtaacccact 11820
cgtgcaccca actgatcttc agcatctttt actttcacca gcgtttctgg gtgagcaaaa 11880
acaggaaggc aaaatgccgc aaaaaaggga ataagggcga cacggaaatg ttgaatactc 11940
atactcttcc tttttcaata ttattgaagc atttatcagg gttattgtct catgagcgga 12000
tacatatttg aatgtattta gaaaaataaa caaatagggg ttccgcgcac atttccccga 12060
aaagtgccac ctgacgtcta agaaaccatt attatcatga cattaaccta taaaaatagg 12120
cgtatcacga ggccctttcg tctcgcgcgt ttcggtgatg acggtgaaaa cctctgacac 12180
atgcagctcc cggagacggt cacagcttgt ctgtaagcgg atgccgggag cagacaagcc 12240
cgtcagggcg cgtcagcggg tgttggcggg tgtcggggct ggcttaacta tgcggcatca 12300
gagcagattg tactgagagt gcaccatatg cggtgtgaaa taccgcacag atgcgtaagg 12360
agaaaatacc gcatcaggcg ccattcgcca ttcaggctgc gcaactgttg ggaagggcga 12420
tcggtgcggg cctcttcgct attacgccag ctggcgaaag ggggatgtgc tgcaaggcga 12480
ttaagttggg taacgccagg gttttcccag tcacgacgtt gtaaaacgac ggccagtgaa 12540
ttg 12543
<210> 16
<211> 48
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 16
caactaatta ttcgaaacgg aattcaccat gggtgctcaa gtttctac 48
<210> 17
<211> 51
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 17
ctgtatttaa atggccggcc ggtacctcat tattgagaaa cagcttgtct c 51
<210> 18
<211> 49
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 18
caactaatta ttcgaaacgg aattcaccat gggtattcca gctgagttg 49
<210> 19
<211> 52
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 19
ctgtatttaa atggccggcc ggtacctcat tattgcaaaa cagcttgttg ag 52
<210> 20
<211> 47
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 20
caactaatta ttcgaaacgg aattcaccat gggcgaccgg gtggccg 47
<210> 21
<211> 51
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 21
ctgtatttaa atggccggcc ggtacctcat tacagtgtgg tgatggcggt c 51
<210> 22
<211> 50
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 22
acaactaatt attcgaaacg gaattcacca tggagacggg ggccacgtcc 50
<210> 23
<211> 50
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 23
acaactaatt attcgaaacg gaattcacca tgaacggggt tttggaaacg 50
Claims (12)
1.一种多核苷酸,其特征在于,所述多核苷酸包括编码柯萨奇病毒A10的VP0、VP1和VP3衣壳蛋白的核苷酸,所述多核苷酸不包括RBS序列和编码柯萨奇病毒A10其他衣壳蛋白的核苷酸,所述编码柯萨奇病毒A10的VP0衣壳蛋白的核苷酸编码氨基酸序列如SEQ ID NO:3所示的VP0衣壳蛋白,所述编码柯萨奇病毒A10的VP3衣壳蛋白的核苷酸编码氨基酸序列如SEQID NO:4所示的VP3衣壳蛋白,所述柯萨奇病毒A10的VP1衣壳蛋白为在SEQ ID NO:5所示的氨基酸序列的N端截短50-72个氨基酸后得到的VP1衣壳蛋白,所述多核苷酸中各核苷酸的排列为:启动子-VP0-终止子-启动子-VP3-终止子-启动子-VP1-终止子。
2.如权利要求1所述的多核苷酸,其特征在于,还包括以下中的一项或几项:
1)编码柯萨奇病毒A10的VP0衣壳蛋白的核苷酸的序列如SEQ ID NO:8所示;
2)编码柯萨奇病毒A10的VP3衣壳蛋白的核苷酸的序列如SEQ ID NO:9所示;
3)编码柯萨奇病毒A10的VP1衣壳蛋白的核苷酸的序列如SEQ ID NO:11或SEQ ID NO:12所示。
3.如权利要求1所述的多核苷酸,其特征在于,还包括:所述编码柯萨奇病毒A10的VP1衣壳蛋白的核苷酸编码氨基酸序列如SEQ ID NO:6或SEQ ID NO:7所示的VP1衣壳蛋白。
4.一种核酸构建体,其特征在于,所述核酸构建体包括权利要求1-3任一所述的多核苷酸。
5.根据权利要求4所述的核酸构建体,其特征在于,所述核酸构建体的表达载体为酵母表达载体。
6.根据权利要求4所述的核酸构建体,其特征在于,所述核酸构建体的核苷酸序列如SEQ ID NO:13或SEQ ID NO:14或SEQ ID NO:15所示。
7.一种细胞系,其特征在于,所述细胞系中包括权利要求4-6任一所述的核酸构建体,或基因组中整合有权利要求1-3任一所述的多核苷酸。
8.根据权利要求7所述的细胞系,其特征在于,所述细胞系为毕赤酵母细胞系。
9.一种重组柯萨奇病毒A10病毒样颗粒,其特征在于,所述重组柯萨奇病毒A10病毒样颗粒包括VP0、VP3和VP1衣壳蛋白,不包括柯萨奇病毒A10其他衣壳蛋白,所述重组柯萨奇病毒A10病毒样颗粒由权利要求7或8所述的细胞系产生。
10.权利要求9所述的重组柯萨奇病毒A10病毒样颗粒在制备预防手足口病产品中的用途。
11.一种用于预防手足口病的药物组合物,其特征在于,所述药物组合物包括权利要求9所述的重组柯萨奇病毒A10病毒样颗粒和药学上可接受的载体。
12.根据权利要求11所述的药物组合物,所述药物组合物为疫苗组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110962246.7A CN115707778B (zh) | 2021-08-20 | 2021-08-20 | 重组柯萨奇病毒a10病毒样颗粒及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110962246.7A CN115707778B (zh) | 2021-08-20 | 2021-08-20 | 重组柯萨奇病毒a10病毒样颗粒及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115707778A CN115707778A (zh) | 2023-02-21 |
CN115707778B true CN115707778B (zh) | 2023-11-03 |
Family
ID=85212758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110962246.7A Active CN115707778B (zh) | 2021-08-20 | 2021-08-20 | 重组柯萨奇病毒a10病毒样颗粒及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115707778B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117783524B (zh) * | 2024-02-26 | 2024-05-03 | 中国医学科学院医学生物学研究所 | 一种双抗体夹心法间接定量检测柯萨奇a10型病毒抗原的建立与应用 |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102839183A (zh) * | 2011-09-02 | 2012-12-26 | 北华大学 | 重组肠道病毒71型病毒样颗粒的制备方法与应用 |
WO2015179979A1 (en) * | 2014-05-28 | 2015-12-03 | National Health Research Institutes | Viral particles as immunogens against enterovirus infection and production thereof |
CN106554965A (zh) * | 2015-09-28 | 2017-04-05 | 斯澳生物科技(苏州)有限公司 | 用于制备ev71病毒样颗粒的核酸构建体和方法 |
CN107557347A (zh) * | 2016-06-30 | 2018-01-09 | 中国科学院上海巴斯德研究所 | 肠道病毒71型的新型病毒样颗粒、其制备方法及应用 |
CN107746832A (zh) * | 2017-10-12 | 2018-03-02 | 泰山医学院 | 一株高滴度的柯萨奇病毒a10驯化株及其应用 |
CN108624609A (zh) * | 2017-03-24 | 2018-10-09 | 斯澳生物科技(苏州)有限公司 | 用于制备柯萨奇病毒a16型病毒样颗粒的核酸构建体和方法 |
CN108624601A (zh) * | 2017-03-17 | 2018-10-09 | 中国科学院上海巴斯德研究所 | 酵母表达的柯萨奇病毒a10病毒样颗粒及其应用 |
CN110256539A (zh) * | 2019-07-10 | 2019-09-20 | 苏州世诺生物技术有限公司 | O型口蹄疫病毒新型基因工程亚单位疫苗 |
CN110938140A (zh) * | 2019-12-27 | 2020-03-31 | 北京科兴生物制品有限公司 | 柯萨奇病毒a10型实心病毒的单克隆抗体及其应用 |
CN111778168A (zh) * | 2020-06-19 | 2020-10-16 | 北京民海生物科技有限公司 | 高效表达ca10病毒样颗粒的汉逊酵母工程菌及其应用 |
CN112375746A (zh) * | 2020-11-12 | 2021-02-19 | 武汉生物制品研究所有限责任公司 | 一株柯萨奇a组2型病毒突变株及其应用 |
CN112724206A (zh) * | 2021-01-22 | 2021-04-30 | 众盈生物(青岛)有限公司 | 一种肠道病毒ev71型病毒样颗粒、编码基因、表达载体、重组酵母菌及制备方法和应用 |
JP2021070629A (ja) * | 2018-02-20 | 2021-05-06 | 一般財団法人阪大微生物病研究会 | エンテロウイルスワクチン |
CN113564130A (zh) * | 2021-09-23 | 2021-10-29 | 北京民海生物科技有限公司 | 柯萨奇病毒a10型毒株及其应用 |
CN114774372A (zh) * | 2022-06-22 | 2022-07-22 | 北京民海生物科技有限公司 | 柯萨奇病毒a10型毒株及其疫苗和应用 |
CN114836443A (zh) * | 2022-05-07 | 2022-08-02 | 华淞(上海)生物医药科技有限公司 | 重组柯萨奇病毒a10 vlp及其用途 |
CN115707776A (zh) * | 2021-08-20 | 2023-02-21 | 华淞(上海)生物医药科技有限公司 | 重组柯萨奇病毒a6病毒样颗粒及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI558812B (zh) * | 2012-03-20 | 2016-11-21 | 國立清華大學 | 類病毒顆粒的製備方法及其使用的重組桿狀病毒 |
US20150056244A1 (en) * | 2013-08-25 | 2015-02-26 | Sentinext Therapeutics Sdn Bhd | Antigens and Vaccines Directed Against Human Enteroviruses |
WO2018067000A1 (en) * | 2016-10-07 | 2018-04-12 | Sentinext Therapeutics Sdn Bhd | Expression cassettes and methods for obtaining enterovirus virus-like particles |
WO2018066999A2 (en) * | 2016-10-07 | 2018-04-12 | Sentinext Therapeutics Sdn Bhd | Chimeric enterovirus virus-like particles |
-
2021
- 2021-08-20 CN CN202110962246.7A patent/CN115707778B/zh active Active
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102839183A (zh) * | 2011-09-02 | 2012-12-26 | 北华大学 | 重组肠道病毒71型病毒样颗粒的制备方法与应用 |
WO2015179979A1 (en) * | 2014-05-28 | 2015-12-03 | National Health Research Institutes | Viral particles as immunogens against enterovirus infection and production thereof |
CN106661102A (zh) * | 2014-05-28 | 2017-05-10 | 财团法人卫生研究院 | 作为对抗肠病毒感染之免疫原的病毒颗粒及其制造 |
CN106554965A (zh) * | 2015-09-28 | 2017-04-05 | 斯澳生物科技(苏州)有限公司 | 用于制备ev71病毒样颗粒的核酸构建体和方法 |
CN107557347A (zh) * | 2016-06-30 | 2018-01-09 | 中国科学院上海巴斯德研究所 | 肠道病毒71型的新型病毒样颗粒、其制备方法及应用 |
CN108624601A (zh) * | 2017-03-17 | 2018-10-09 | 中国科学院上海巴斯德研究所 | 酵母表达的柯萨奇病毒a10病毒样颗粒及其应用 |
CN108624609A (zh) * | 2017-03-24 | 2018-10-09 | 斯澳生物科技(苏州)有限公司 | 用于制备柯萨奇病毒a16型病毒样颗粒的核酸构建体和方法 |
CN107746832A (zh) * | 2017-10-12 | 2018-03-02 | 泰山医学院 | 一株高滴度的柯萨奇病毒a10驯化株及其应用 |
JP2021070629A (ja) * | 2018-02-20 | 2021-05-06 | 一般財団法人阪大微生物病研究会 | エンテロウイルスワクチン |
CN110256539A (zh) * | 2019-07-10 | 2019-09-20 | 苏州世诺生物技术有限公司 | O型口蹄疫病毒新型基因工程亚单位疫苗 |
CN110938140A (zh) * | 2019-12-27 | 2020-03-31 | 北京科兴生物制品有限公司 | 柯萨奇病毒a10型实心病毒的单克隆抗体及其应用 |
CN111778168A (zh) * | 2020-06-19 | 2020-10-16 | 北京民海生物科技有限公司 | 高效表达ca10病毒样颗粒的汉逊酵母工程菌及其应用 |
CN112375746A (zh) * | 2020-11-12 | 2021-02-19 | 武汉生物制品研究所有限责任公司 | 一株柯萨奇a组2型病毒突变株及其应用 |
CN112724206A (zh) * | 2021-01-22 | 2021-04-30 | 众盈生物(青岛)有限公司 | 一种肠道病毒ev71型病毒样颗粒、编码基因、表达载体、重组酵母菌及制备方法和应用 |
CN115707776A (zh) * | 2021-08-20 | 2023-02-21 | 华淞(上海)生物医药科技有限公司 | 重组柯萨奇病毒a6病毒样颗粒及其用途 |
CN113564130A (zh) * | 2021-09-23 | 2021-10-29 | 北京民海生物科技有限公司 | 柯萨奇病毒a10型毒株及其应用 |
CN114836443A (zh) * | 2022-05-07 | 2022-08-02 | 华淞(上海)生物医药科技有限公司 | 重组柯萨奇病毒a10 vlp及其用途 |
CN114774372A (zh) * | 2022-06-22 | 2022-07-22 | 北京民海生物科技有限公司 | 柯萨奇病毒a10型毒株及其疫苗和应用 |
Non-Patent Citations (11)
Title |
---|
A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection;Zhou Y 等;《Antiviral Res》(第152期);第124-130页 * |
A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity;Zhang W 等;《Emerg Microbes Infect》;第7卷(第1期);第1-12页 * |
Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enteroviruses;Chen J 等;《Cell Discov》;第5卷;第1-15页 * |
CVA10候选疫苗病毒株的分离、鉴定及其致病性和免疫保护性研究;仝凯 等;《免疫学杂志》;第35卷(第6期);第471-477页 * |
CVA10致手足口病的流行情况与疫苗研究进展;高微捷 等;《医学研究杂志》;第48卷(第9期);第9-12页 * |
polyprotein [Coxsackievirus A10];Ng T等;《GenBank Database》;Accession:QJA28496.1 * |
Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice;Dai W 等;《Antiviral Res》(第164期);第139-146页 * |
Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating;Zhu L 等;《Nat Commun》;第9卷(第1期);第1-9页 * |
柯萨奇病毒A10型致手足口病的研究进展;仝凯 等;《世界最新医学信息文摘》;第19卷(第37期);第76-78页 * |
柯萨奇病毒A组10型研究进展;崔博沛 等;《微生物学免疫学进展》;第46期(第2期);第63-67页 * |
柯萨奇病毒A组16型病毒样颗粒的制备及其免疫原性;陈祥鹏 等;《中国生物制品学杂志》;第27卷(第11期);第1361-1368页 * |
Also Published As
Publication number | Publication date |
---|---|
CN115707778A (zh) | 2023-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107002095B (zh) | 用于治疗溶酶体贮积症的腺伴随病毒载体 | |
AU2017202195B2 (en) | Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof | |
AU2013322635C1 (en) | Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications | |
DK2828384T3 (en) | PROCEDURE FOR SURVIVING SENSITIVITY TO CHEMICAL DNA MODIFICATIONS OF CONSTRUCTED SPEECH DNA BINDING DOMAINS | |
KR20150143816A (ko) | 조작된 페닐알라닌 암모니아 리아제 폴리펩티드 | |
CN110892062A (zh) | 表达耳畸蛋白的组合物和方法 | |
KR20100051632A (ko) | Fsh 제조 세포 클론 | |
CN115707778B (zh) | 重组柯萨奇病毒a10病毒样颗粒及其用途 | |
CN110214182A (zh) | 用于i型黏多糖贮积症的基因治疗 | |
CN110564772B (zh) | 改造宿主细胞基因组的方法及其用途 | |
CN111850127A (zh) | Ntng1蛋白在制备用于肝癌诊断试剂或试剂盒中的用途 | |
CN115707777B (zh) | 重组肠道病毒a71病毒样颗粒及其用途 | |
CN114196705A (zh) | 一种重组腺相关病毒包装质粒、重组腺相关病毒及其应用 | |
CN111886342A (zh) | 拉沙疫苗 | |
KR20100084689A (ko) | Hcv ns3 단백질분해효소 레플리콘 셔틀 벡터 | |
IL200299A (en) | Nucleic Acid Sequence Encoded by Gne from a Wild Species for Use in Modulating Sial Acid Production in a System Containing Mammalian Muscle Tissue | |
CN115707779B (zh) | 重组柯萨奇病毒a16病毒样颗粒及其用途 | |
CN111893185A (zh) | 表达ntng1基因的细胞株的构建方法和应用 | |
CN109929847B (zh) | 一种pex26基因、蛋白及其应用 | |
CN113637672B (zh) | 一种碱基编辑工具及其构建方法 | |
CN108118007A (zh) | 一种基因工程菌生产β-胡萝卜素的方法及其基因工程菌 | |
KR101446388B1 (ko) | B형 간염 바이러스의 preS1 W4P 변이 단백질을 발현하는 형질전환 동물 및 이의 용도 | |
CN113652450A (zh) | 慢病毒载体的制备方法及得到的慢病毒载体和应用 | |
KR102543504B1 (ko) | 세포 손상 관찰을 위한 형광 단백질 변이체 및 이를 이용한 약물 독성 평가 방법 | |
CN110777147A (zh) | 一种ikzf3基因沉默的t细胞及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |